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8SUMMARY OF THESIS
Renal transplantation (tx) restores kidney function temporarily and improves the prospects of 
a normal life as compared to dialysis. During the last forty years great progress has been made 
in renal transplantation and its follow up treatment. However, preserving long-term graft 
function is still a major challenge. Therefore, it is crucial to review our practices in pediatric 
transplantation and to evaluate patient outcome as the first step in enhancing future prospects.
Following renal tx a chronic multifactorial physical and mental condition persists both for the 
child and its caregivers. Life-long dependence on immunosuppressive treatment (IS) and 
concomitant comorbidities after tx (e.g. progressive decline in renal function, hypertension, 
hyperlipidemia and excessive weight gain) render these children at increased risk for future 
cardiovascular (CV) morbidity and mortality. Based on structural and functional 
echocardiographic findings post-tx, these children have been forecast a rather gloomy CV 
prognosis including cardiomyopathy and heart failure in adult life. However, little attention 
has so far been paid to the levels of physical activity and cardiorespiratory fitness (CR fitness, 
V02peak) as  global markers of CV health and physical functioning in tx children and adult
survivors. Furthermore, more knowledge is required of the impact of tx on health related 
quality of life (HRQOL) for the child and its caregivers following, predominantly, parental 
kidney donation.
Aims
The overall aim of this study was to evaluate long-term outcome after renal tx in childhood. 
In paper I, the purpose was to investigate the long-term patient and graft survival during 
1970-2006 in a pediatric cohort receiving renal grafts mainly from living donors (LD).
In the cross-sectional (CS) studies (papers II-IV) the objective was to increase the knowledge 
of health outcomes after tx in childhood, with emphasis on the level of CR fitness as a marker 
of CV function. Moreover, in recipients of predominantly parental donor organs, the aim was 
to investigate the children and their caregivers’ perceptions of mental health and HRQOL.
9Design
The HENT study (Helse Etter Nyre Transplantasjon i barnealder) was designed as a national 
follow-up study after renal tx in childhood consisting of 1) a historical cohort study (2007, 
paper I) and  2) a cross-sectional (CS) study of children and adolescents (papers II and IV) 
and young adults (paper III) renal tx after 1983. The CS studies were performed during 2008-
2010.
Methods
Survival data and baseline characteristics were obtained from the Norwegian Renal Registry 
and medical records. Crude patient and graft survival were calculated using the Kaplan-Meier 
method. Cox proportional hazards model was used to determine predictors of graft survival.
In the CS studies, CR fitness (V02peak) was assessed with treadmill exercise testing. 24-hour 
ambulatory blood-pressure monitoring (ABPM), oral glucose tolerance test (OGTT),
estimation of glomerular filtration rate (eGFR), blood sampling and anthropometric measures 
were also performed. Physical activity (PA) and quality of life issues were self-reported by 
questionnaire. Body composition was measured by dual-energy X-ray absorptiometry (DXA, 
adults only).
Main Results
Living donor graft (84% of all transplantations) was the only significant positive predictor for 
graft survival, with estimated median graft survival being twice as long for LD (median 16.7 
years) as compared to that of deceased donors (DD) (median 7.7 years). Graft survival did not 
improve significantly across treatment eras. Twenty years patient survival was 84.4% and one 
third of the deaths were caused by cardiovascular disease/sudden death (paper I).
Tx children obtained a median V02peak of 66% of healthy controls, with the majority reporting
low levels of physical activity (paper II). Reduced CR fitness was associated with the 
clustering of CV risk factors (>1 of impaired glucose intolerance, hypertension and BMI z-
score >2) (paper II). Tx children’s mental health, psychosocial adjustments and quality of life 
were for most criteria significantly impaired on both self-reports and mothers’ proxy reports 
compared with healthy controls, and in several areas also lower than children with acute 
lymphoblastic leukemia (ALL). CR fitness was positively associated with quality of life;
while a higher BMI z-score was negatively associated with mental health score (papers II and 
IV).
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In the young adults who received a renal tx in childhood (ped-tx), median V02peak was reduced 
by 15% as compared to healthy controls. V02peak was not significantly reduced compared to 
adult recipients of similar age tx in adulthood (adult-tx).
Conclusions and future perspectives
The use of LD organs offers the best premise for graft survival and pre-emptive tx is the first-
line preventive strategy to reduce CV risk. The future challenge is to translate the use of more 
potent IS treatment and reduced acute rejection rates into prolonged graft survival while 
concomitantly addressing weight gain, hypertension and physical inactivity. A multifactorial 
approach is needed in the rehabilitation of these children, recognizing that physical 
functioning, body habitus and quality of life measures are interdependent measures.
Optimizing psychosocial outcome requires in-depth interviews with the child and the parents 
and relevant interventions regarding their perceived barriers to quality of life. Larger 
prospective studies are proposed to investigate the role of V02peak as a prognostic marker for 
future CV events in tx populations. While awaiting such results, physical activity should be 
encouraged in chronic kidney disease (CKD) and be a mandatory part of the rehabilitation 
program for tx children and adolescents hand-in-hand with medical and psychosocial support. 
This strategy may ameliorate the potential hazards of inactivity and enhance social 
interaction.
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2. INTRODUCTION
2.1 Definition and classification of chronic kidney disease in children
The Kidney Disease Outcomes Quality Initiative (KDOQI) of the National Kidney 
Foundation (NKF) defines chronic kidney disease (CKD) as either kidney damage 
(proteinuria) or a decreased kidney glomerular filtration rate (GFR) of less than 60 
ml/min/1.73 m2 for  three or more months (88). CKD is stratified into five stages: Stage I 
(GFR >90ml/min/1.73m2), stage II (GFR 60-90), stage III ( 30-59), stage IV (15-29) and stage 
V (GFR<15 ml/min/1.73m2 = end stage renal disease, ESRD) (70). The classification stages 
have been applied to adults and children with CKD, including renal allograft recipients 
(70;177).
2.2 Epidemiology of ESRD in children
The annual incidence of renal replacement therapy (RRT) among European children 
(< 15 years old) was 6.5 per million age related population (pmarp) in 2007 (161). The point 
prevalence was 33.6 pmarp, of whom two-thirds had a functioning renal graft and the 
remaining third were on dialysis. In 2009 a total of 292 people received renal tx in Norway, of
whom eight were less than 15 years old, thus children represented 2.7% of all renal 
transplants.
2.3 Causes of ESRD in children
Most renal diseases in childhood leading to ESRD are (in descending frequency); congenital 
structural abnormalities (aplasia/hypoplasia/dysplasia/obstructive uropathy); hereditary 
diseases and acquired diseases. The relative distribution varies by race and classification (63)
and some diseases are more prevalent due to ethnicity (e.g. Finnish-type nephrotic syndrome).
Structural malformations occur more frequently in young children whereas 
glomerulonephritis, nephronophthisis and focal segmental glomerulosclerosis account for the 
majority of renal diseases in older children and adolescents (63).
2.4 Renal replacement therapy 
The point where chronic kidney disease reaches end stage marks the start of a lifelong 
dependence on renal replacement therapy (RRT). The options for RRT include dialysis 
(hemodialysis or peritoneal dialysis), preemptive renal tx or renal tx preceded by dialysis.
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Although renal tx is the best choice for quality of life and survival, dialysis is the alternative 
option to sustain life, most often used as a bridge to renal tx. Despite advances in dialysis 
technology and expertise dialysis treatment still has a four and 30 times higher mortality risk 
compared to those receiving tx and healthy children, respectively (99). Cardiovascular 
diseases are the most common cause of death in children with ESRD, ranging from 23-57% of 
causes of death (99;128). Projected life expectancy of adolescents >18 years exposed to RRT 
from childhood onwards, is estimated  at 63 years for those transplanted but only 38 years for 
those remaining on dialysis (82). The importance of pre-emptive tx and avoidance of long-
term dialysis has been emphasized as a major preventive strategy for later CV disease (176).
2.5 Historical overview of pediatric renal transplantation 
In 1959 Goodwin and Murray performed the first successful transplantation between identical 
twins in Boston. Murray was rewarded with the Nobel Prize in 1990 for this pioneering work 
(124). The first successful non-twin pediatric transplant was performed in 1962 by Starzl et al 
in The United States. A 12-year old boy received a kidney from his mother, the graft lasted 3
years under cover of Azathioprine (AZA)/ prednisolone and irradiation treatment (152). The 
first pediatric renal transplantation in Norway took place two years later in 1964, when a 
father donated a kidney to his 8 year old son. The graft survived three years (personal 
communication; Dagfinn Albrechtsen). In 1970 the Norwegian children`s official tx program 
was established, resulting in dramatically improved life expectancy for children with end 
stage renal disease (ESRD). Living donor (LD), in particular living related donor tx, has been 
the treatment of choice since the inception of the program. Except for three pediatric patients,
tx at Oslo University Hospital (OUS) Ullevål prior to 1983, all renal tx in children has been 
performed at OUS, Rikshospitalet (National Transplant Center from 1983).
2.5.1 Immunosuppressive drugs
The calcineurin inhibitors (CNIs) comprise of cyclosporine (Cya), originally isolated from a 
fungus, and tacrolimus (Tac), a macrolide antibiotic. Cya and Tac exert their
immunosuppressive action by inhibiting the calcineurin enzyme responsible for activation of 
DNA binding proteins that stimulate the production of IL-2, one of the cytokines involved in 
leukocyte proliferation (126).
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Azathioprine (AZA), an imidazolyl derivate of 6-mercaptopurine, antagonizes purine 
metabolism and inhibits the synthesis of DNA, RNA and proteins. An alternative to 
azathioprine is Mycophenolate (MMF), which acts by inhibiting de novo purine synthesis.
Widely used prednisolone, is a synthetic corticosteroid which has predominantly
glucocorticoid activity. Prednisolone exerts its immunosuppressive effect (albeit incompletely 
understood) by decreasing the expression of several cytokines, chemokines and growth 
factors. Among the effects are poor antigen presentation by antigen-presenting cells and 
reduced T-lymphocyte response and effect (cellular immunity).
Basiliximab and daclizumab (induction therapy agents) are interleukin-2 (IL-2) receptor 
antagonists and work by binding to the CD25 antigen at the surface of activated T-
lymphocytes and thereby inhibit IL-2 mediated lymphocyte activation, an important step in 
cellular immune response in allograft rejection. Other treatments that act on lymphocytes 
include the lymphocyte depleting agents such as: antithymocyte globulin (ATG);
antilymphocyte globulin (ALG) and monomurab-CD3. ATG is used in steroid resistant 
rejections at Oslo University Hospital, Rikshospitalet.
The mammalian target of rapamycin inhibitor(s) (mTORi) sirolimus and everolimus, have 
emerged as complementary immunosuppressive alternatives.
Calcineurin inhibitors still constitute the cornerstone of IS treatment in children. Cya has been 
superseded by Tac, currently accounting for 74% of the CNI`s (63). Tac is commonly 
combined with MMF and daily low-dose steroids/alternate day steroids. However, steroid 
withdrawal or even avoidance has shown promising results under the cover of induction 
therapy (57;69).
2.5.2 Immunosuppressive eras - advances in medical treatment
AZA was the first effective immunosuppressive option in addition to corticosteroids, and 
these two agents became the first line anti-rejection treatment in Norway from 1970-1983 (era 
I). Previously, acute rejections were managed with steroids and irradiation of the graft (108).
In the early 1980s, Cya was introduced as a new immunosuppressive agent. Cya represented a
major turning point for organ tx worldwide as the drug reduced acute rejections and increased 
short term survival of the renal graft (119). Cya was included in the Norwegian tx program 
from January 1983, either in combination with steroids or in triple treatment with AZA until 
1999 (era II). It was about this time that it was noticed that steroid dosages could be lowered 
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post-tx leading to better conditions for growth (41). However, after the success of Cya it soon 
became evident that the short-term benefit of Cya on graft survival was at the expense of 
chronic nephrotoxicity reducing long-term graft survival (81). The dependence on CNI`s in 
pediatric IS treatment has been a double edged sword ever since. Improvements in Cya 
formulations evolved from a hydrophobic agent to a microemulsion formulation (Neoral, 
available in Norway from 1995), which lead to a more consistent absorption rate (126).
From the year 2000 onwards (era III), basiliximab was added as an induction therapy at the 
day of surgery and at the fourth postoperative day. Simultaneously, Cya was replaced with 
Tac as the CNI treatment of choice. Until recently, the Norwegian pediatric maintenance IS 
protocol consisted of induction therapy (basiliximab), duotherapy with CNI (Tac) and 
prednisolone. As of October 2010, triple therapy with tacrolimus, prednisolone and MMF has
been introduced as the preferred maintenance IS treatment, similar to the adult protocol.
2.5.3 Acute rejections and chronic allograft nephropathy
In the pioneering days of transplantation, hyperacute and acute allograft rejection was the 
main obstacle towards graft survival. An acute rejection episode involves injury to the graft
driven by T cells and/or antibodies reacting to donor antigens (MHC molecules) expressed on
the surface of donor cells (113). The development of new potent IS combinations, better 
immunological matching, pharmacokinetic monitoring (125) and use of protocol biopsies, 
have been some of the factors contributing to lowering the rate of acute rejections (113).
According to the North American Pediatric Renal Trials and Collaborative Studies
(NAPRTCS) registry report, acute rejection rate has decreased steadily over the years from 
>60% in 1987-1990 to about 13% since 2007 (146).
Historically, the slow decline in graft function was named “chronic rejection” and the 
diagnosis was rarely accompanied by graft biopsies in the early years but instead relied on 
measuring increasing levels of serum creatinine. The term has later been replaced with 
“chronic allograft nephropathy”(CAN) or IF/TA ( interstitial fibrosis/ tubular atrophy) (149).
The causes of CAN/ IFTA are multifactorial and include: chronic antibody-mediated 
rejection; hypertension and CNI toxicity (113). CAN remains the most common cause of graft 
loss, accounting for 40% of cases (146).
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2.5.4 Graft survival and donorship in pediatric renal transplantation
At the turn of the millennium, long-term follow-up studies of ESRD/ renal tx from childhood 
emerged from several tx centers in Europe. One, five, ten and twenty year estimated graft 
survival in European countries (tx during 1970-2001) ranged from 85-86%, 59-77%, 46-66%, 
and 30.9-38%, respectively. Patient survival ranged from 91-95%, 89-98%, 86-89% and 71-
89% at 1, 5, 10 and 20 years, respectively (31;32;59;102;133;159). The introduction of Cya in 
the 1980s significantly improved short and medium-term graft survival (102;119;133).
LD organ graft survival has been superior to that of deceased donors (DD) in all centers. The 
10 year graft survival ranges from 54- 74% for LD recipients and 43-51% for DD recipients
(31;32;59;102;133;159). LD and in particular living related donors, confers several benefits to 
the recipient beyond that of increased graft survival and is increasingly advocated (67;72). It 
reduces time on the waiting list, and in most cases surgery can be planned and performed 
without prior dialysis thus avoiding dialysis-related morbidity. Moreover, LD recipients 
experience improved growth (127) and the prevalence of post-tx hypertension is lower (150).
There has been a steady increase in LD recipients over time, comprising 50% -60% in the 
American pediatric tx registries (67;114).However, DD organs still constitute the majority of 
the kidneys grafted in most tx centers in Europe (82;133;159). Sweden is the exception; LD 
kidneys currently comprise approximately 78 % of donated grafts (personal communication 
Ulla Berg).
Irrespective of RRT, no changes in patient survival for either dialysis or transplant patients 
occurred between the study periods 1992-1999 versus 2000-2007 according to a recent 
Canadian registry report (135). The finding is consistent with the NAPRTCS and the United 
States Renal Data System (USRDS) reports; patient and graft survival has remained static for 
pediatric ESRD/ tx patients for the last two decades (11;114). Thus, strategies that may 
improve long-term outcomes by preventing late allograft loss will increase life expectancy 
and is therefore a current priority in pediatric renal tx.
2.6 Comorbidities of chronic kidney disease and after renal transplantation
Progressive CKD and the ensuing tx entails unique challenges that require constant evaluation 
besides monitoring graft survival issues. Potential comorbidities include adverse effects on 
linear growth, osteodystrophy, risk of infections, hypertension, reduced glucose 
tolerance/diabetes, dyslipidemia, weight gain and in the long run CV diseases and 
malignancies. Lastly, the burden of a persisting chronic disease and its consequences affects
family functioning and the quality of life of children and their parents.
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2.6.1 Childhood growth with chronic kidney disease and after renal transplantation
Historically, growth retardation has been the hallmark of CKD in childhood. Linear growth is 
hampered as a consequence of the metabolic and inflammatory changes of CKD (acidosis, 
malnutrition and derangements in the growth hormone axis) (40). Post-tx, linear growth 
generally improves but is counteracted by corticosteroids and residual renal failure (33).
Moreover, age at tx plays a major role; the younger recipients (<6 years of age) have the 
greater height deficits at time of tx than older children, but experience better catch-up growth 
post tx compared to older children (66). Adequate nutrition prior to tx, minimizing steroid 
exposure (57) and the introduction of recombinant human growth hormone have contributed 
to decreased growth deficits in the last two decades. Data obtained from the NAPRTCS
registry have shown a steady improvement in linear growth, as the z-score at tx has improved 
from -2.4 in 1987 to -1.3 in the 2007 cohort. However, 25% of those currently reaching adult 
height are growth retarded (height z-score<-2) (114). Favourable final height results were
recently presented in a Swedish report on outcome after renal tx in childhood; mean adult 
height was 171cm for males (-1.35 SDS) and 161cm for females (-0.67SDS) (116).
2.6.2 Chronic kidney disease and cardiovascular risk
Children with chronic kidney disease have a higher prevalence both of the “classical” CV risk 
factors as well as the “non-classical” (uremic) CV risk factors, as compared to healthy 
children. The classical risk factors include hyperlipidemia, hypertension and insulin 
resistance, the most significant being hypertension in terms of its role in vascular damage and 
re-modelling (92). Research on the complex mechanisms of “non-classical CV risk factors” 
has led to a better understanding of the precursors of vasculopathy that occur early in pediatric 
CKD. Dysregulations in the calcium-phosphate metabolism and vitamin D axis, including
secondary hyperparathyroidism, are believed to be the driving force of vascular damage
leading to media calcification in the arteries (141;143). Vascular calcification and the ensuing 
vascular stiffness starts to develop in the early stages of CKD, increasing with time on
dialysis and is not reversed by renal tx in the short term (142;143). In pediatric patients with 
CKD, uremic derived factors are believed to be the main contributors to cardiovascular 
morbidity and mortality rather than atherosclerosis (91).
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2.7 Cardiovascular risk factors after pediatric renal transplantation
The prevalence of young adults with a history of renal tx during childhood is currently 
increasing (82). However, despite increased life prospects survivors of childhood tx have 
more than a 10-fold increased risk of cardiovascular (CV) death compared to the general 
population (133). At present only a minority of the renal tx child population has yet reached 
middle age (>50 years), when the cumulative effect of age, heredity and CV burden since 
childhood will reach its full impact. 
Successful kidney tx corrects many of the metabolic abnormalities associated with ESRD, but 
the post-tx state introduces its own comorbidities related to IS treatment such as persistence of 
renal insufficiency and consequences of a chronic disorder per se. Renal tx children/ children 
with CKD have been classified in the highest risk stratum for future CV disease along with 
children with diabetes type I and homozygous familial hypercholesterolemia (77).
2.7.1 Long-term outcome after pediatric renal tx and cardiovascular disease
The Late Effects of Renal Insufficiency in Children (LERIC) study is a comprehensive Dutch 
cohort study on physical and psychological effects after ESRD onset in childhood between 
1972-1992 (58;59). Cardiovascular sequela in adult survivors (mean age 29.2, n=140) 
included left ventricular hypertrophy (LVH) in 47% of males and 39% of females; 19% had 
aortic valve calcifications, and arterial stiffness was increased compared to controls (60). In 
another study by Oh et al, coronary artery calcifications were found in 92% of young adults 
(19-39 years old) with childhood onset ESRD (120). However, the predictive value of 
coronary calcifications on future CV morbidity and mortality has not yet been established.
Infections and cardiovascular disease comprise the most prevalent causes of death in tx 
children, accounting for 27-56% (133;156;159) and 21-41 % (61;99;119;133;156)
respectively. As CV events and death are rare in childhood and young adulthood after tx (lack 
of significant numbers), intermediate CV risk factors have been used as alternative outcome 
measures since they occur more frequently (46), some of which are given below.
2.7.2 Chronic kidney disease
Tx is not a cure from  chronic kidney disease; CKD stage III-IV exists in 48%-62% of
children post-tx (36;173), and as such GFR has been claimed to be underappreciated as a key 
factor inherent of several complications post- renal tx (38), including its role as a risk factor 
for CV death (103). Approximately 50% of those undergoing tx in childhood will need a 
second renal tx before the age of 25 years (52).
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2.7.3 Hypertension 
Post-transplant hypertension (HT) is a common complication after renal tx and affects 60-
87% depending on the method of BP measurement, definition and the normative data used 
(137). Moreover, in 30-62% of subjects high blood pressure (BP) is insufficiently treated 
(37;37;138). The etiology of HT is multifactorial and includes native kidneys, CNIs, steroids, 
obesity, and reduced GFR (137). Ambulatory blood pressure measurement (ABPM) is 
generally regarded superior to office blood pressure, both in children and adult tx recipients 
(37;105;106;154) and is increasingly incorporated in routine surveillance of pediatric renal tx 
recipients. As opposed to causal BP measurements, ABPM reveals night-time hypertension, 
uncovers masked and white coat hypertension and provides a better overall assessment of 
antihypertensive treatment efficacy (85;100;137). In fact, as showed by Krmar et al, repeated 
monitoring of ABPM at regular intervals improves BP control (85).
Hypertension is a risk factor for graft loss (150) and is a predictor of CV mortality in adults
(95). However, in contrast to adult studies, most reports have failed to show a correlation 
between hypertension and left ventricular hypertrophy (LVH) in tx children (100;109).
Furthermore BP control (measured by ABPM) over time has not been shown to improve 
carotid intima media thickness (cIMT) in children, suggesting that factors other than 
hypertension are more decisive contributors to both LVH and increased cIMT in childhood
(84). On the other hand, in young adults with ESRD since childhood (Dutch Cohort study), 
hypertension was shown to be an independent risk factor for LVH (62).
2.7.4 Left ventricular hypertrophy
LVH is a common cardiac abnormality in pediatric CKD and after tx. LVH is a predictor of
mortality among adults (42). In children with CKD, LVH is particularly frequent in ESRD 
due to volume overload and hypertension (104). LVH improves after tx, but does not resolve 
completely and has been associated with persistent diastolic dysfunction several years after 
renal tx (80;105). The frequency of LVH reported post-tx ranges from 6% to 82% 
(9;97;105;107) depending on the tx cohort investigated and definitions used for LVH. 
Nevertheless, concern has been raised as to whether concomitant diastolic dysfunction
acquired in childhood will progress and limit physical functioning, or even develop into 
congestive heart failure in adulthood (105).
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2.7.5 Overweight/obesity
In the western world healthy children and adults are facing an obesity epidemic as a result of 
the imbalance of energy intake and expenditure. This trend is also currently being adopted in 
children with CKD (39) and after tx, (65) leading to further aggravation of the CV risk in
these patients. Post-tx the increase in appetite as a result of steroids and regain of renal 
function is welcomed by most parents, but is unfortunately not balanced by an adequate 
activity level. Longitudinal studies have shown the prevalence of obesity in tx children 
(BMI>95th percentile) to increase from 13% at tx to >30%  3-12 months post-tx (24), and 
persisting thereafter (45) to act as an independent predictor of hypertension (24). According to
a report from the NAPRTCS, obese (BMI>95th percentile) children aged 6-12 years have a
higher relative risk (RR 2.9-3.6) for death than non-obese tx children (65). In adult recipients, 
BMI at 1 year post-tx is a strong predictor of death and graft failure (71).
2.7.6 Glucose intolerance/ diabetes, hyperlipidemia and metabolic syndrome
Diabetes is less common in pediatric than in adult renal recipients. Registry data from the 
USRDS found a 3-year incidence of diabetes of 7% in pediatric renal tx; the risk factors being 
obesity and the use of tacrolimus versus cyclosporin (16). Hyperlipidemia is a common side-
effect of IS treatment following pediatric renal tx and contributes to the risk for CV disease.
Hypercholesterolemia (total cholesterol>200mg/dl, 6.1mmol/l) post-tx has been reported in 
15-45% of tx children, elevated LDL (>130mg/dl) in 10-13%, while triglycerides >150mg/dl 
(>1.7mmol/l) has been reported in 30-45% in renal tx children (10;144;145).
Coexistence or clustering of CV risk factors is a common finding after renal tx in childhood.
However, controversy exists around whether metabolic syndrome (MS) is applicable in the 
context of renal tx patients since tx in itself constitutes a distinct metabolic risk profile 
attributable to persistent renal failure and use of immunosuppressives. Furthermore, in 
children no uniform definition on MS has been established on whether obesity, with its close 
link to insulin resistance, is a mandatory criterion of MS or not. Depending on the definition 
used, MS in children post-tx ranges from 25-37% in single center studies (131;175). Whether 
a constellation of metabolic CV risk factors in childhood tx track to adulthood, and 
furthermore is predictive for CV diseases in adulthood has yet to be determined.
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2.8 Physical activity and cardiorespiratory fitness in CKD and after tx
In children with progressive CKD participation in physical activity may be reduced due to the 
physical and psychological consequences of renal failure. Uremia, acidosis and anemia 
contribute to fatigue and muscle wasting (44). The chronic disease in itself and time spent 
away from peers renders the child at risk for a sedentary lifestyle creating a vicious circle of 
inactivity and isolation. Several studies point to the lack of physical activity and decreased CR 
fitness both prior to and after pediatric tx in this patient group (13;35;50;83;96;121;139;167).
Only one longitudinal study with 9 pediatric participants explored the change in V02peak from 
dialysis until 3 months post-tx (121). No significant spontaneous improvements in CR fitness 
were found in this small study, whereas in adult recipients CR fitness appears to improve after 
tx, but does not normalize (122).
In the adult population V02peak is a strong predictor of morbidity and mortality, both in healthy 
individuals and in those with established CV disease (34) (12;112). In fact CR fitness / 
exercise capacity has been claimed to be a more powerful predictor of CV outcome than 
hypertension, hyperlipidemia and obesity (111). Repeated exercise testing has shown that 
changes in CR fitness is strongly associated with changes in mortality (34). Adult tx recipients 
in general have reduced CR fitness compared to healthy subjects (122) but muscle strength,
CR fitness and quality of life improves significantly with exercise (79). At present, no studies 
have assessed the effect of improved CR fitness on long-term mortality or morbidity in tx 
recipients. Nevertheless, the importance of exercise in adults with CKD and post-tx, has been 
increasingly acknowledged; A whole issue of the Advances in Chronic Kidney Disease was
recently devoted to the importance of physical exercise in CKD populations (Vol 16, No 6, 
November 2009).
2.9 Psychosocial/quality of life issues
Tx is a milestone for children and their families after years lived with declining renal 
function. The child regains energy, appetite and renal function. However, contrary to the 
expectations of both the parents and the child, living with a transplant is yet another chronic 
disease with its own hazards and comorbidities. Rejection of the graft and subsequent graft 
loss is a constant threat for both the child and the caregivers. Frequent hospital visits and daily 
medications with cosmetic side effects are reminders of an everlasting chronic disease.
Previous research in children with advanced CKD has generally confirmed an increased risk 
of impaired mental health, psychosocial functioning and quality of life (55;101). Tx children 
report better psychosocial functioning and HRQOL than children on dialysis, but worse than 
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their healthy counterparts (6;55;64;101). Only a few studies have focused on the parents’ 
psychosocial functioning and HRQOL after LD kidney donation. Despite overall
improvement in family functioning following tx, including better personal relationship with 
their child (117), several parents express psychological distress and uncertainty about their 
child`s future (76). Most HRQOL studies on CKD children and adolescents have highlighted 
on the psychosocial effects, with less attention paid to its relation to physical effect, but higher 
levels of PA have been associated with better HRQOL (64).
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3. AIMS OF THE STUDY
The purpose of our study was to establish a historical overview of pediatric graft and patient 
survival and to evaluate measures of health outcome after renal tx with emphasis on CR 
fitness and quality of life. 
The main research questions to be addressed were (1-4):
1. What is the overall graft and patient survival after renal transplantation in childhood 
across eras, and what are the predictors of graft survival?
2. What is the level of CR fitness of tx children and adolescents as compared to healthy 
controls?
 Are physical activity and CR fitness associated with other CV risk 
factors in renal tx children?
3. What is the level of CR fitness in childhood tx subjects reaching adult life compared 
to adult recipients and healthy controls? 
4. Given the predominance of parental organ donation in Norway, what are the 
children`s and their caregivers’ perceptions of mental health and quality of life 
following renal transplantation?
 Are somatic health variables associated with mental health and 
quality of life measures?
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4. SUBJECTS AND METHODS:
4.1.1 Design – papers I-IV
The HENT study (“Helse Etter Nyre Transplantasjon i barnealder”) was designed as a 
national follow-up study after renal tx in childhood, consisting of: 1) a historical cohort study 
(paper I) and 2) a cross-sectional (CS) study of Norwegian tx children and adolescents (papers
II and IV) and young adults (paper III). The historical prospective cohort study was carried 
out during 2007; the CS studies were performed during 2008-2010.
4.1.2 Subjects – paper I
Patient and graft survival were assessed in children undergoing their first renal tx from 1970 
until December 31th 2006 (n=178). Tx data on children aged 1-16 years were obtained from 
the Norwegian Renal Registry (NRR) and the medical records at OUS Rikshospitalet and 
Ullevål and were reviewed for supplementary patient data. Information retrieved included 
baseline clinical characteristics, native kidney disease, donor characteristics, pretransplant 
dialysis time, patient and graft survival, acute rejection episodes, causes of graft failure and 
causes of death. 
Ethnicity
Eighteen children (10 %) were of non-Norwegian descent, including patients from Pakistan 
(n=8), India (n=1), Vietnam (n=1), South-America (n=3), Macedonia (n=1), Turkey (n=2), 
Albania (n=1) and Nigeria (n=1) (unpublished data from medical records).
Immunosuppressive treatment eras
In order to reflect different treatment protocols throughout the years and their possible impact 
on graft survival we divided the study period 1970-2006 in three treatment eras: 
1. 1970-1982, when AZA and prednisolone were maintenance treatment; 2. 1983-1999 when 
Cya was introduced either in conjunction with prednisolone alone, or as a combined triple 
regimen including AZA;
3. 2000-2006, when antibody induction therapy (basiliximab) was combined with Tac and 
prednisolone.
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4.1.3 Subjects – papers II and IV
Tx children in Norway pay annual visits to OUS Rikshospitalet until transition to adult care at 
about 18 years of age. From this population, children and adolescents aged 2-19 years old, 
receiving tx between 1993 until 31.12.2006 were invited with their respective parents to 
participate in a CS study involving a two-day comprehensive medical investigation program 
(Table 1). The inclusion criterion for participation in the CS study was a functioning graft for 
at least one year (GFR>20). Of a pool of n = 56 children and adolescents, four patients were 
excluded due to graft loss (dialysis) and two patients died. Thus, 50 eligible children/parents
were invited and thirty-eight (76%) agreed to participate in whole or in parts of the program, 
Figure 1. Participants were enrolled from May 2008 to June 2009. There were no significant 
differences in sex, renal function, or proportion of LD recipients between the 38 participants 
and those who declined participation (n=12) but non-participants were significantly older than 
the participants; median age 13 (3-19) versus16.9 (6-20) years (paper IV).
4.1.4 Subjects – Paper II
Of the 38 participants in the CS study, 26 were eligible for treadmill testing. Exclusion criteria 
for the exercise test were children < 8 years old (too young for test requirements, n=7) and 
patients with orthopedic limitations (n= 5). Two adolescent girls who participated in the CS 
study refused exercise testing. Two adolescent boys ended the test before maximal effort was 
attained. Thus, twenty-two participants completed the exercise testing (Figure 1). Eligible 
non-participants (> 8 years of age, n=13ª, Figure1) were significantly older than the 
participants; 17.4 (13-20) years versus median 14.5 (8.6-18.9) years, respectively (p=0.01)
otherwise no significant differences were found regarding sex, proportion of overweight, GFR 
or number of transplants.
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Pool of renal tx children 
2-19 years old tx until 
31.12.2006
n=56
Dead n=2 Excluded  n=4*
Invited to cross-sectional study  
n=50
participants paper IV
n=38
Declined participation
n=12ª
Treadmill participants
n=24
Excluded, n=12***Declined treadmill 
participation n=2ª
Completed treadmill test
 n=22, paper II
Not maximal effort
 n=2
Figure 1: Recruitment of participants paper II and IV. 
 *exclusion criteria: Dialysis, < 1 year since last tx.
 ªeligible non-participants paper II: n= 2 + 12 - 1 (aged < 8 years of age) = 13.
 ***Children < 8 years old or physical restrictions (n=7 and n=5 respectively).
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Table 1: The schedule for investigations in the CS studies.
The investigations presented in papers II-IV are shown in bold.
*questionnaires on physical activity and quality of life/mental health (pages 29-31)
***performed in adults only (paper III).
ªpublished in children and adolescents only (paper II)
4.1.5 Subjects – paper III
Subjects > 19 years old with a history of tx in childhood transitioned to the adult local 
nephrology centers, were identified from the NRR. Inclusion criteria were: functioning graft 
>1 year; no major locomotor or musculoskeletal restrictions on weight bearing activities; no
symptomatic cardiac disease and undergoing first tx > 19831
1 Two patients, one tx in 1981 and the other in December 1982, were included in the study (both were started on 
Cya from 1983 onwards).
. Subjects on dialysis or <1 year 
since last tx (n=6), > 3 renal tx (n=1), orthopedic restrictions (n=3), conditions involving 
mental retardation and/or blindness (n=6), heart failure following myocardial infarction (n=1), 
severe epilepsy/ hydrocephalus (n=2) and lost-to follow up (n=1), were excluded. Twelve 
patients died. In total fifty-seven patients aged 19-41 years, transplanted between 1983-2002
met the inclusion criteria at the start of the study and were invited to participate (Figure 2). 
Participants had to be free of recent infections and acute rejections (2 weeks and 3 months 
DAY 1 DAY 2
Anthropometrics
Interview/questionnaires*
Fasting blood samples
Start 24-h ABPMª
Iohexol GFR
Stop 24-h ABPMª
Oral glucose tolerance testª Echocardiogram
Dual-X-ray absorptiometry
Bone density/Body composition***
Treadmill exercise test
Summary with investigator
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prior to study start, respectively). Forty one (70%) agreed to participate. During the inclusion 
period an additional 9 adults were excluded due to loss of graft function (n=3), infections 
(n=2) and another five adults cancelled/ did not show up. Information regarding s-creatinine, 
weight and height in eligible non-participants, was obtained from the NRR annual report 
(2009). There were no significant differences between the final treadmill participants (n=31) 
versus eligible non-participants (n=21) with regard to age, sex, eGFR (MDRD), time since 
first tx, BMI, pretransplant dialysis time or proportion of LD (tx1). Participants tended to be 
retransplanted more often; 14(45%) compared to 7/21 (33%) of non-participants, however the 
difference was not significant (p=0.1).
Controls paper III
A control group of adult-tx recipients tx after the age of 19 but < 35 years living within the 
suburban area of Rikshospitalet were identified from the NRR (n= 36). Seven had orthopedic 
restrictions and two were pregnant. Twenty-seven recipients were invited to participate. Six 
subjects did not respond to the invitation. Of the remaining 21 all agreed to participate but 
only 17 met at the scheduled treadmill/DXA test. Thirty-six Norwegian blood donors of 
comparable age and sex recruited from an ongoing prospective treadmill test study were 
included as a healthy control group for the treadmill test results. Results from the tx patients 
were also compared to Norwegian V02peak treadmill reference values recently published (3).
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Pool of adults  aged 19-41
renal Tx 1 in childhood after 
1983
n= 89
Dead n= 12
Excluded from study
n= 20*
Eligible participants
n= 57
Accepted written invitation, 
n= 41 (70%)
Declined invitation 
n= 9ª
No response to 
invitation n= 7ª
ESRD/other disease 
 n= 5
Cancelled n= 5ª
Participation
n= 32
 Severe anemia     
n= 1
          Exercise test 
                  n= 31
Figure 2: Recruitment of adult participants. 
* Exclusion criteria, se paragraph 4.1.5, ªeligible non-participants, n= 9a+5a+7a = 21
4.2 Methods
4.2.1 Child physical Activity Questionnaire (paper II)
Children and adolescents completed a 7-day physical activity recall questionnaire consisting 
of 18 items including leisure physical activity and sedentary activities during one week 
(4;148) (appendix A). The questionnaire has previously been validated against an activity 
monitor (Actireg; Norway) in healthy 9-10 year old children and 13-14 year old children
(4;148). The energy intensity for each activity was calculated as MET (metabolic equivalent 
task). MET expresses the intensity of each activity level as compared to resting energy 
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expenditure (1MET =3.5 ml oxygen consumed per kilogram of body weight). Each physical 
activity item was grouped in intensity-specific MET categories according to Ainsworth et al 
(1;2). Mean time spent on moderate activity (3-6 METs) and vigorous activity (> 6 METs) 
during one week was calculated and divided by a factor seven. Sedentary activities were 
defined as 1.3 METs and non-registered remaining time during 24 hours as 1.5 METs. The 
median MET level per 24 hours and self-assessed median time (in minutes) spent on moderate 
to vigorous activity (MVPA) per 24 hours was calculated. 
4.2.2 Adult physical activity questionnaire (paper III)
Participants completed a self administered short version of The International Physical Activity 
Questionnaire (IPAQ short format, S7S, appendix A) which comprises a set of seven
questions on the last seven days of physical activity (PA). The questions register the time 
spent (in bouts of at least 10 minutes and frequency per seven days) in three types of PA; 
walking, moderate and vigorous intensity activities, respectively. It also includes leisure time 
physical activity such as domestic chores and gardening (yard) activities, work-related 
physical activity and transport-related physical activity. Each intensity category of PA was 
weighted according to their respective energy requirements expressed in metabolic 
equivalents (METs) according to IPAQ definitions (www.ipaq.ki.se): Walking = 3.3 METs;
Moderate PA = 4.0 METs and Vigorous PA = 8.0 METs. Total MET-minutes for each 
intensity category was computed by multiplying the MET level by minutes per day and days 
per week. Subjects accumulating > 600 METs-min per week of moderate and vigorous 
activity were categorized as sufficiently active according to international recommendations
(68). IPAQ short format has been developed for international use and has been validated in 12 
countries for the age group 18-65 (20). The IPAQ short format has recently demonstrated 
acceptable reliability for moderate and vigorous PA in Norwegian males against an activity 
monitor (intraclass correlations 0.3-0.8) and satisfactory validity for IPAQ vigorous PA 
against an objective measure of V02peak (r = 0.41) (87). In swedish adults, moderate validity 
(r=0.34) was demonstrated for self-reported total PA (IPAQ)  as compared to total PA 
assessed by accelerometry (30).
.
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4.2.3 The Strength and Difficulties Questionnaire (paper IV)
The Strength and Difficulties Questionnaire (SDQ, appendix B) was used to assess the mental 
and psychosocial health in children and adolescents (56). A proxy version was given to 
parents. There are 5 subscales: Emotional Symptoms, Conduct Problems, Hyperactivity, Peer 
Problems and Prosocial Behavior; the first four adding up to the Total Difficulties Score. 
Subscores are generated for different subscales. The SDQ shows satisfactory reliability and 
validity (56;118). For further details, see the subject and methods section of paper IV.
4.2.4 The Pediatric Quality of Life Inventory (paper IV)
The Pediatric Quality of Life Inventory (PedsQLTM4.0) was used to measure HRQOL in tx
children and adolescents (27), appendix B. The 23-item PedsQLis is grouped into 4 domains 
of HRQOL: 1) Physical Functioning (8 items); 2) Emotional Functioning (5 items); 3) Social 
Functioning (5 items) and 4) School Functioning (5 items). Child self-reports included ages 5 
to 7, 8 to 12 and 13 to 18 years. Parent proxy-reports included ages 2 to 4, 5 to 7, 8 to 12 and 
13 to 18 years, and assessed parents’ perceptions of their child’s HRQOL. The PedsQL 4.0 
has achieved excellent reliability for the Total Scale score (r=0.89) and has been shown to 
differentiate between healthy children and children with chronic health conditions (165). For 
further details, see the subject and methods section in paper IV.
4.2.5 The General Health Questionnaire (paper IV)
The General Health Questionnaire (GHQ, appendix B) is a widely used screening instrument 
for assessing the presence of distress, psychopathology and overall well-being in adults, and 
has showed acceptable reliability and validity (53). For further details, see the subject and 
methods section in paper IV.
4.2.6 The Quality of Life Scale (paper IV)
The Quality of Life Scale (QOLS, appendix B) is a questionnaire measuring adult’s overall 
satisfaction with life based on different life domains (15). The QOLS questionnaire contains 
additional information on areas not usually included in health-related quality of life measures, 
such as independence, material comfort, work satisfaction and recreation. For further details, 
see the subject and methods section in paper IV.
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4.2.7 Exercise testing (papers II and III)
To assess CR fitness (V02peak) the tx participants (papers II and III) and healthy controls 
performed a graded treadmill exercise test until volitional fatigue on a motor-driven treadmill 
(Technogym, Italy,) using the Oslo protocol (48). Spirometry measurements (forced vital 
capacity (FVC) and forced expiratory volume in one second (FEV1)) were performed while
standing prior to the exercise test. The best FEV1/ FVC values of three measurements were 
recorded and expressed as percent predicted of age, height and gender (110;130). The Oslo 
protocol starts at a comfortable walking speed of 5 km h-1 with 2% inclination, thereafter the 
inclination (in 2% steps) and speed (in 1 km h-1 increments) is increased every other minute 
until exhaustion. The healthy adult controls in paper III were tested with a modified Bruce 
protocol on a Woodway (Germany) treadmill (21). A Medical Graphics cardiopulmonary 
exercise system (Sensormedics V-max29, Yorba Linda, Calif.) was used, and expired gas was 
sampled using a Rudolph mask. The expiratory gas was collected and conveyed to a 
spirometer and to oxygen and carbon dioxide detectors. The measurement system was 
calibrated before each test. Oxygen consumption, carbon dioxide production and ventilation 
were measured continuously breath-by-breath. Mean 30second respiratory values were used 
in all calculations. Heart rate was recorded and a 12-lead electrocardiogram was assessed 
throughout the test (Cardiosoft ECG). Oxygen uptake at peak effort was determined and 
referred to as V02peak. Respiratory exchange ratio (RER) was calculated as the ratio of C02
production toV02 consumed. 
In children and adolescents (paper II) a correction for differences in body mass was used by 
multiplying by the factor kg -0.67 (129). The weight-adjusted maximal oxygen uptake (ml kg-
0.67min-1) was defined as CR fitness, also expressed in terms relative to body weight (ml kg-1
min-1). V02peak in participants was compared to a national pediatric reference (n=196) tested 
by the same protocol and assessed by the same scaling factor (kg-0.67) (49). A previous study 
from our Department showed good reproducibility in V02peak; the majority of healthy children
varied less than 5% in V02peak when retested using the Oslo protocol (48). In the adults (paper 
III) V02peak was expressed in terms of l min-1, ml kg -1min-1 and relative to fat free mass (ml 
FFM-1 min -1).
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Requirements for a maximal test in children (paper II)
The test was considered maximal if the participant was unwilling to continue exercising 
despite extensive encouragement from the test supervisor, maximal heart rate (peak HR) 
     	   —age) and respiratory exchange ratio (RER) 
reached 1.0 or more. Subjective annotations from the test leader (rapid breathing/unsteady 
running) were also included in the evaluation of a maximal test. 
Requirements for a maximal test in adults (paper III)
The test was terminated when the participant was unwilling to continue exercising despite 
extensive encouragement from the test supervisor. The criteria for a maximal test was a RER 
value !"	
 and self-perceived exertion rated 17 according to the Borg scale 
(14). Borg`s self-perceived exertion scale ranges from 6 to 20, where 6 means “no exertion at 
all”, 15 is “hard effort”, 17 corresponds to “very hard” (90% effort) and 20 is “complete 
exhaustion”.
4.2.8 24-hour ambulatory blood pressure (ABPM)
24-hour ambulatory blood pressure monitoring (ABPM) was performed using a validated 
portable oscillometric ambulatory blood pressure monitor (Oscar 2, SunTech Medical 
Instruments, USA). Blood pressure (BP) recordings in children were programmed every 20 
minutes from 0600 am to 2200 pm and every 30 minutes from 22pm to 0600 am. Only tests 
with more than 40 recordings with a minimum of 8 readings during the night, were included
(178). Sex and height adjusted mean daytime and nighttime systolic and diastolic BP were 
converted to centiles using the LMS method (178). Thresholds for hypertension (BP 95th
percentile) were given by Wuhl et al (178). Hypertension was defined in subjects with mean 
daytime and/or nighttime systolic and/or diastolic blood pressure (SBP/DBP) 95th percentile 
or using antihypertensive treatment (AT). Uncontrolled hypertension was defined as 
SBP/DBP th percentile whether on AT or not. Participants were regarded normotensive if 
both SPB/DBP were < 95th percentile without AT. Loss of nocturnal decline in blood pressure 
(BP), also designated as the nondipping phenomenom, was defined using adult criteria as a 
night-time BP decline less than 10% for SBP and/or DBP of the corresponding daytime BP.
ABPM measurements in children have shown higher reproducibility than office BP (85;94).
However, a single 24hr recording has been shown to be less reliable in characterizing the
circadian BP profile (94).
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4.2.9 Renal function, biochemistry and metabolism
Measured glomerular filtration rate (mGFR) was measured in tx children and adults (ped-tx) 
using a single intravenous injection of iohexol (0.5 ml/kg) with blood sampling after three 
hours (73;151). In adults only (paper III) GFR (in ml/min/1.73m2) was also estimated using 
the MDRD formula, corrected for s-creatinine, race, gender and sex (89). Values > 60 
ml/min/1.73m2 were coded as 60 when GFR was used as a continuous variable. Venous blood 
samples were obtained after an overnight fast and analyzed for Biochemistry at the Medical 
Laboratory, Rikshospitalet. Plasma-cholesterol, triglycerides, high -density lipoprotein (HDL) 
and low-density lipoprotein (LDL) cholesterol were determined by the enzymatic colorimetric 
method (Roche, Norway). An oral glucose tolerance test (OGTT) was performed after an oral 
glucose load of 1.75g of glucose per kilogram of bodyweight, maximum 75g. Serum-insulin 
was analyzed by enzyme-labeled chemiluminescent immunometric assay (Siemens Medical 
Solutions Diagnostic, AS). Plasma- glucose was measured by enzymatic photometry (Roche, 
Norway). 
4.3 Anthropometrics and dual-energy X-ray absorptiometry 
Height was measured to the nearest 0.1cm using a stadiometer. Weight was measured to the 
nearest 0.1kg on a digital scale wearing light clothing. Waist circumference was measured at 
the midpoint between the bony markers of the ribs and superior iliac crest (paper II) (47).
Body Mass Index (BMI) was calculated as kg/m². In children and adolescents (papers II and 
IV), anthropometric data were converted to standard deviation scores (BMI-z-score and 
height z-score) based on Cole`s LMS method (19). In children the calculations of z-scores 
were performed using the Pfizer International Growth Database (KIGS) Auxology Calculator 
for PC software (Pfizer Endocrine CareTM). Overweight and obesity in children and 
adolescents were defined according to age and sex adjusted BMI centile cut-off limits
corresponding to BMI> 25 kg/m² and >30 kg/m² at age 18 (18). Adults >19 years of age
(paper III) were defined as underweight if BMI < 18.5 kg/ m², normal weight if BMI was 
18.5-24.9, overweight if their BMI was 25-29.9 and obese if BMI >30 kg/m².
In adult renal tx recipients (paper III), body composition was measured by means of dual-
energy X-ray absorptiometry (DXA). Whole-body and segmental body composition (upper 
limbs, lower limbs and trunk) were measured using a GE Lunar Prodigy densitometer (GE 
Medical Systems Lunar Corp., Madison, WI, USA). The obtained data were evaluated using 
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enCORE 2006 software (v10.10; GE Healthcare, Madison, WI, USA), which calculates the 
fat mass (FM; kg), percentage of fat mass of the total body mass (FM %) and lean body mass 
(LBM; kg). Fat-free mass (FFM; kg) was calculated as the sum of LBM and bone mineral 
content. Fat mass index (FMI) was calculated as FM/m2.
4.4 Outcomes and definitions
Acute rejection
The term acute rejection (AR) included both early and late acute rejection episodes. Early 
acute rejection episodes were defined by a rise in s-creatinine of at least 20% or as decided by 
the physician, accompanied by antirejection therapy within 6 months after tx. 
Chronic rejection
Progressive decline in renal function expressed as a slow increase in serum creatinine, 
excluding other causes if possible.
CKD- stratification
Measured GFR (iohexol) and estimated GFR (MDRD) were stratified into 5 stages of CKD as 
presented on page 12.
Standard deviation score (SDS/ Z-score) for height/BMI
Patient`s height/BMI - mean height/BMI for age/ standard deviation of height/BMI for age.
Metabolic syndrome 
Metabolic syndrome was defined when three or more of the following criteria were fulfilled, 
modified after Weiss et al (169): BMI z-score ; hypertension defined as age and sex 
matched mSBP/mDBP th percentile and/or use of antihypertensive medication; P-HDL < 
40mg/dl (<1.03mmol/l); P-Triglycerides >150mg/dl (#$%; impaired glucose 
tolerance (IGT) defined as two hours sampling glucose level > 140mg/dl but less than 
200mg/dl (>7.8mmol/l and <11.1mmol/l, respectively). 
Definition of V02 peak/ CR fitness
Maximal oxygen uptake (V02 max) is defined as the maximal capacity of the cardiopulmonary 
system to supply oxygen to the working muscles and the ability of muscles to use oxygen 
through the process of aerobic metabolism(166). V02 max describes the highest attainable 
oxygen uptake that does not rise further despite an increase in work rate (166). As the real
V02 max is rarely achievable during treadmill testing, the highest oxygen uptake achieved 
during testing is termed V02 peak. The concepts CR fitness and V02 peak are used 
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interchangeably throughout the thesis. Other terms used in the literature that refer to V02peak
are aerobic capacity and aerobic fitness.
Ergometry methods
V02peak is generally assessed either by cycle or treadmill ergometry, both in children and 
adults. The treadmill test is regarded the best objective assessment of V02peak since it engages 
a larger muscle mass than the cycle ergometer, and the V02peak is therefore more likely to be 
limited by central (cardiac output) rather than peripheral factors (muscle) (115). Cycle 
ergometry is to a greater extent dependent on muscle power in the quadriceps muscle and 
increases the likelihood of premature termination of the test due to anaerobic metabolism and 
muscle pain (115).
Allometric scaling (AS)
Allometric scaling describes the method whereby V02 peak is adjusted to body weight raised to 
a given power other than unity (e.g. ml kg -0.67min-1) to better account for differences in body 
weight as V02 peak (l min-1 ) does not increase linear to body weight.
Physical activity
Physical activity (PA) encompasses all kinds of body movement during leisure time or work 
that increases skeletal muscle work and energy consumption. The dimensions of physical 
activity can be described by the intensity, frequency, duration and type of activity performed.
PA and CR fitness are strongly linked, but represent two complementary ways of measuring 
physical health (157). PA is difficult to measure due to its complex nature, while CR fitness is 
easier to assess objectively by direct gas exchange measurements during maximal exercise.
Exercise capacity
In this thesis is defined as the duration of exercise on the treadmill.
RER
Respiratory exchange ratio: The ratio of C02 production to V02 consumption. A ratio >1.0 and 
&
'	(	'
	"exercise test in children and adults, 
respectively.
MET
Metabolic equivalent: One MET is the amount of energy used by an average adult at rest =
3.5 ml oxygen consumed per kilogram of bodyweight.
Ped-tx 
Young adults with a history of first renal tx in childhood (< 16 years old).
Adult-tx
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Young adults with a history of first renal tx in adulthood (19years old).
4.5 Statistical analyses
General, Papers I-IV 
Data were described with median and range (continuous variables), or as proportions and 
percentages (categorical variables). 95% confidence intervals (CI) for proportions were 
constructed using the f-distribution approximation. For continuous variables, the differences 
between groups were analyzed using an unpaired (two-sided) t-test (normally distributed data) 
or Mann-Whitney Wilcoxon test (variables with skewed distribution). The non-parametric 
Wilkoxon signed rank test was used to analyze the difference between two continuous 
variables when the same individual was measured several times. Associations between 
categorical variables were assessed using a Chi-squared test or Fisher’s exact test for small 
samples. The strength of crude associations between normally distributed continuous 
variables was measured using Pearson`s correlation coefficient or Spearman’s correlation 
coefficient when the variables had a skewed distribution. All statistical tests were two-sided, a
p-value < 0.05 was considered statistically significant. All statistical analyzes were performed 
using SPSS ver 13-16.
Paper I
Crude patient and graft survival were calculated using the Kaplan-Meier method and 
computed with follow up times of 5, 10, 15 and 20 years. Crude survival curves between 
groups were compared with the log-rank-test. Graft survival was defined as the time from 
transplantation to the graft loss or to the end of study (31.12.2006). Graft loss (event) was 
defined as 1) the date of death with functioning graft (uncensored death), 2) the date for return 
to dialysis or 3) the date of a new pre-emptive transplant. Patient survival was defined as the 
time from tx to death or to the end of the study. Censoring: survival time was censored for 
those who had not yet experienced an event by the end of study (31.12.2006). No patients in 
our study were lost to follow-up. To evaluate possible predictors of graft survival measured at 
the time of tx, Cox proportional hazards model was fitted and adjusted for LD/DD, diagnosis, 
dialysis prior to tx, donor age, sex, and immunosuppressive era. The model was stratified by 
age-groups (0-6 years, 7-11 years and 12-15 years) due to non-proportionality.
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Paper III
Possible predictors of V02peak (l min-1) as the dependent variable were evaluated using 
univariate linear regression analysis. Variables with a p-value < 0.1 from the univariate 
analyses were entered into a multiple linear regression model. Highly correlated independent 
variables (r >0.7) could not be entered in the same model (due to multi-colinearity); thus the 
variables sex and height were not included because of their high correlation with the variable 
FFM (r=0.78 and 0.79), which we regarded as more clinically relevant. A careful check of the 
model assumptions including an investigation of residual plots was performed.  
Sample size
No previous study has compared the level of V02 peak between adult survivors of childhood tx 
to that of adult tx subjects. Therefore, in paper III we had little or no guidance to quantify the 
clinically relevant (mean V02 peak) difference between the tx groups. We based our assumption 
on other V02 peak studies in adult tx patients, in which mean V02 peak was reduced with 20-25% 
as compared with healthy controls (79). To detect a mean V02 peak (ml kg -1min -1) difference 
of ~20% between ped-tx and adult-tx, we calculated (two sample t-test, SD 10) that the study
would require 25 patients in each group (power of 80% and a significance level of 5%, 
http://statpages.org.
Paper IV
A multiple linear regression analysis was used to assess possible explanatory variables as 
predictors for mental health (SDQ) and quality of life (HRQOL). Variables with p<0.05 from 
the univariate analyses were included in the multiple linear regression model. Possible 
explanatory variables included age, sex and the physical correlates (height, BMI, V02peak) and 
maternal correlates (GHQ, QOLS). A careful check of the model assumptions, including an 
investigation of residual plots was performed.
4.6 Ethical considerations
Written informed consent was obtained prior to study start from children and adults >16 years 
of age or their parents if less than 16 years old. Participants were informed that they could 
withdraw from the study at any time. The Norwegian Data Inspectorate and the Regional 
Committee for Medical and Health Research Ethics in South Eastern Norway approved the 
HENT study. 
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5. MAIN RESULTS
5.1 Graft and patient survival after renal transplantation in childhood (paper I)
During 1970-2006, 178 children underwent their first renal tx at a median age of 11.1 (0.8-
15.9) years. Eighty-four percent of pediatric recipients received a kidney from a LD,
predominantly parents (86 %). Fifty-one percent were transplanted pre-emptively, dialysis 
time prior to tx was median 3 months. The unadjusted estimated median graft survival was 
16.9 years for LD grafts versus median 7.7 years for DD organs (log rank, p= 0.008, Figure 
3). LD graft was the only significant predictor of better graft survival (HR=2.1, 95% CI [1.1-
4] as compared to DD grafts when adjusted for pretransplant dialysis, diagnosis, sex, donor 
age and immunosuppressive era. There was a trend towards improved 1 and 5-year graft 
survival from era II (1983-1999) to era III (2000-2006) (Figure 4), however the difference 
was not statistical significant. Acute rejection rates decreased from 61.5 % in era I to 14.5% in 
era III (p=0.002). Estimated cumulative 20 year patient survival rate was median 84.4%
(Figure 5). The main causes of death were infections (38%) and cardiovascular events (33%).
Chronic rejection (60%) was the far most common cause of graft loss.
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Figure 3: Graft survival of living donor transplantation versus deceased donor:
Donor Graft survival 1970-2006 (tx1, %)
1 year 5 years 10 years 15 years 20 years
LD (n=149) 93.2 82.0 68.8 57 45.1
DD (n=29) 75.9 59.6 43.3 27.1
P= 0.008
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-- - - - - 1970-1982 (n=35)
_ _ _ _ 1983-1999 (n=88)
______2000-2006 (n=55)
Grafts at risk
1970-82 :   23 20 18                 13
1983-99:    71 51                   27                 13
2000-06: 19 - - -
P=0,48
* Extending the last era until June 2010: There was a trend towards increased 1 year graft 
survival from 1983-1999 to 2000-2010, p=0.097, unpublished data.
Figure 4: Graft survival in three eras
Era of tx Graft survival (%)
1 year 5 years 10 years 15 years 20years 25years
1970-1982 (n=35) 88.6 65.7 57.1 51.4 37.1 31.2
1983-1999 (n=88) 88.6 80.7 65.1 48.6 42.1
2000-2006 (n=55) 94.4 84.6 -
2000-2010 (n=71)* 96 85 72
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Patients at risk:
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P=0,22
Figure 5: Patient survival 1970-2006
Donor Patient survival 1970-2006 (tx1, %)
1 year 5 years 10 years 15 years 20 years
LD (n=149) 95.9 95.2 95.2 89.8 86.3
DD (n=29) 93.1 89.2 84.5 79.2 79.2
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5.2 CR fitness in renal tx children and adolescents compared to healthy children
(paper II)
 Associations of CR fitness with CV risk factors in renal tx children (paper II)
In this cross-sectional follow-up study, 24 (63% of eligible) children and adolescents 
participated in a two day comprehensive study (Table 1) which included the assessment of 
V02peak, a maximal treadmill test and a self-reported physical activity questionnaire. Twenty-
two participants completed the treadmill test until exhaustion and were included in further 
analysis (Figure 1). Median age was 14.5 (8.6-18.5) years and time since tx 1 was median 5.2
(1.1-14.2) years. All patients had GFR > 20 ml/min/1.73m2 and Hgb >10g/dl. All were non-
smokers, none had overt cardiac disorders. Nineteen children (86%) reported less than 60 
minutes of recommended daily MVPA. V02peak was significantly correlated with MVPA (r 
=0.49, p=0.03). V02peak was median 33.5 (18-59) ml kg -1min -1 in tx children and 53 (35-72) 
ml kg -1min -1in the reference population (n=196, p<0.001, Figure 6).When V02peak was 
expressed relative to body weight -0.67 min-1 the study subjects obtained median 66% (36 to 
97) of expected V02peak of healthy Norwegian children of comparable age and sex. Only three 
participants obtained V02peak within the expected range of healthy references (i.e. V02peak z-
score >-2).
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Figure 6. Comparison of pediatric renal tx male and female peak treadmill exercise values 
(V02peak) to a reference child population (49).
Sixteen (73%) of the treadmill participants were either hypertensive on ABPM or treated with 
antihypertensive medication. Eight children (36%) were overweight (n=4) or obese (n=4), 
median BMI z-score was 0.6 (-1.8-6.9). P-cholesterol was elevated (>200mg/dl) in five 
children. P-TG >150mg/dl was found in 2/22 and decreased HDL (< 40mg/dl) in n= 4 
children. None of the children were receiving lipid- lowering agents at the time of the study. 
Three children had impaired glucose tolerance, none had overt diabetes. Four children (18%) 
fulfilled the criteria for the metabolic syndrome.
Children with at least 2 of 3 metabolic risk factors (hypertension, overweight and glucose 
intolerance, n=7) achieved significantly lower V02peak compared to those with one or none of 
these risk factors (median V02peak= 45% and 73% of expected, respectively, p=0.003). 
Children with one or less metabolic risk factors reported significantly more daily physical 
activity than children with two or three risk factors (median MVPA 36 minutes versus 23 
minutes, respectively, p =0.02). 
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5.3 CR fitness in adults with a history of renal tx in childhood (paper III)
 Compared to adult transplanted subjects (adult-tx) and healthy controls
Study participants were enrolled in this cross-sectional study from September 2009 to 
November 2010. Of the eligible adults with a history of renal tx in childhood (ped-tx), 41 
(70%) agreed to participate, 31(~60%) completed a treadmill exercise test (Figure 6).
Seventeen adults of comparable age transplanted in adulthood (adult-tx) were recruited as
controls (page 28). Forty-eight young adults, 31 ped-tx and 17 adult-tx were tested on a 
maximal treadmill test until exhaustion. Thirty-six Norwegian blood donors of comparable 
age and sex, previously treadmill tested in an ongoing prospective study, were included as a
healthy control group (HC). Median age was 26.9 (19-41) years, 28.6 (23.5-34) years and 
33.5 (20-42) years in the three groups, respectively. Time since first tx was median 18.1 (7-
29) years for ped-tx participants and 3.7 years (1.2-12.6) for adult-tx. There were no 
significant differences regarding age, sex or BMI between ped-tx, adult-tx and HC. Moreover, 
there were no significant differences between ped-tx and adult-tx in terms of total time spent 
on dialysis prior to tx, FM%, self-reported total PA, s- Hgb or GFR (MDRD).
V02peak was median 37.9 (12.5-56.3), 40.8 (26.5-57.5) and 44.4 (29.5-65.6) ml kg -1min -1 in 
the ped-tx, adult-tx and HC, respectively (Figure 7). Ped-tx had significantly lower V02peak
compared to HC (p=0.01). Ped-tx achieved on average 85% of the V02peak of HC. V02peak was 
not significantly lower in ped-tx compared to adult-tx when expressed relative to body weight 
(ml kg -1min -1) but tended to be reduced in ped-tx when expressed as FFM (V02peak 55.2 (30-
68) and 58.1 (39.7-64.5) ml FFM -1min-1, respectively, p=0.09). Adult-tx had higher exercise 
capacity (test duration) compared to ped-tx (median 10.5 (7.5-16) and 9 (6-14) minutes, 
respectively (p=0.016). In multiple linear regression analysis, test duration in minutes, fat-free 
mass (FFM, kg) and Hgb (g/dl) were significant predictors of V02peak explaining 86% of its 
variance. Total PA, tx participant group and FVC were not independent predictors of V02peak
when adjusting for other covariates.
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Figure 7. Treadmill exercise values
The horizontal lines indicate min-max and median values.
Ped-tx: young adults renal tx in childhood (< 16 years of age); adult-tx: young adults renal tx
in adulthood (	
and HC: healthy controls
5.4 Renal tx children and their caregivers’ perceptions of mental health and 
quality of life after renal tx (paper IV)
 Associations between somatic health variables and mental health and quality of
life issues
In this paper, the purpose was to assess mental health and health-related quality of life
(HRQOL) in children and their parents after renal tx compared to healthy controls and to 
children previously treated for Acute Lymphoblastic Leukemia (ALL), and to identify 
possible health-status variables associated with mental health and HRQOL.
Thirty-eight tx children and adolescents participated (76%), median age 13 years (range 3-
19). The majority (n=34, 89%) had received a kidney from a LD of which 27 (79%) were 
donated from parents. Parental information was obtained from 32 mothers, median age 40.5 
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years. Healthy children (n=42) and children previously diagnosed with ALL (n=40) (and their 
respective mothers) were included as controls and comparison groups, respectively. Both tx 
children and their mothers (proxy version) reported significantly higher total SDQ difficulty
scores on the mental/psychosocial health questionnaire than healthy control children and the 
children with ALL. Moreover, tx children and their mothers (proxy version) reported 
significantly lower HRQOL scores on all PedsQL items except for emotional functioning, 
than healthy controls and the ALL group.
The mothers of tx children reported significantly more mental health problems (GHQ-case) 
than the mothers of healthy controls, but the QOLS scores in mothers of tx children did not 
differ significantly from that obtained from the general Norwegian population.
BMI z-score was the only significant predictor of tx children`s mental health outcome (SDQ 
total score as the dependent variable) in multiple linear regression, explaining 32% of the 
variance (p=0.018). Using PedsQL total score as the dependent variable, V02peak was the only 
significant predictor of quality of life outcome (n=22), explaining 42% of the variance 
(p=0.005). Age, gender, height, and the parental correlates (GHQ, HRQOL scores) were not 
independent predictors for the quality of life (PedsQL) or mental health (SDQ total score).
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6. DISCUSSION
6.1 Graft and patient survival after renal transplantation in childhood (paper I)
The main finding of this study was that LD organs (84%) provided the best graft survival. 
Cumulative patient survival (84% after 20 years) and graft survival were comparable with 
other long-term reports on children receiving predominantly LD organs (31;140;147).
The benefits of LD organ donation on graft survival and reduced mortality is increasingly 
being recognized (22;67;132). However, in most tx centers in Europe DD kidneys still 
comprise the majority of the organs grafted (82;133;159). In the Nordic countries, only 
Sweden has from the inception had the same tx policy as Norway with a high proportion of 
LD organs and with the intention to minimize dialysis prior to tx (31). Shroff et al has shown 
that the vascular calcification, a marker of arteriosclerosis, increases with time in dialysis, and 
may only be partially reversed after renal tx (143). The extra mortality risk associated with
dialysis is manifested as reduced projected life expectancy, being approximately 25 years 
shorter for adolescents remaining in dialysis versus those with a functioning graft (82). Thus, 
preemptive tx and avoidance of long-term dialysis remains the key strategy in reducing 
exposure to CV risk factors in children with ESRD (99;176).
There was a tendency towards, but not a significantly improved overall graft survival across 
eras of emerging new treatment strategies, nor was the ”era effect” a predictor for LD graft 
survival, despite a decreased number of acute rejections across the last eras. Due to a limited 
number of events our study may have been underpowered to detect a small improvement in
graft survival over time. In addition, with concomitant progress in expertise and more potent 
IS treatment there has been counteracting effects such as the acceptance of children
< 2 years in the tx programs after 1988, contributing to an increased non-renal comorbidity
and risk of early graft loss. From 2000 onwards, the shift to Tac as the preferred CNI drug 
was done gradually, thus the era effect on graft survival could be shrouded by lack of protocol 
consistency. Moreover, until recently the Norwegian pediatric tx program diverged from other 
centers as the maintenance protocol consisted of duotherapy of CNIs and prednisolone only.
Hence, the possibility of relatively more nephrotoxic effects of CNIs could be partly 
responsible for the lack of improvements in graft survival between the last two eras. Thus, as 
of October 2010, MMF has been added (triple regimen) as a CNI minimizing strategy. 
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The success of pediatric transplantation as measured by patient and graft survival yielded 
good results in agreement with other comparable tx programs. Our next step was to evaluate 
health outcome aspects after renal tx in childhood; given in the following papers.
6.2 CR fitness in renal tx children and adolescents compared to healthy children
(paper II)
 Associations of CR fitness with other CV risk factors in renal tx children
Our main finding was that in a group of stable renal tx children (n=22), median V02peak was 
only 66% of that of healthy controls, and most of the participants rated themselves as physical 
inactive (86% < 60 min PA per day). Our findings are in agreement with other reports on PA 
in renal tx children; although PA levels are measured differently in each study, and therefore 
limits comparison, they all point to low PA (13;35;50;64;83;96). Our favorable pre-tx 
conditions with no or minimal dialysis did not yield  more favorable CR fitness results but 
were in line numerically (expressed in ml kg-1 min-1) with the few published treadmill 
exercise studies reporting V02peak values in tx children (83;121).
To put it in perspective, our finding is  comparable to V02peak results of children with Fontan 
circulation previously treadmill tested with the same protocol, test leader and healthy control 
population as in our study (98). These children obtained a mean V02peak of 70% of the 
expected age and gender reference values comparable to our results. CR fitness of children 
with Fontan circulation was limited by hemodynamic changes and reduced lung function (98).
The explanation for the poor test result in the group of tx children is probably complex,
possibly related to central (cardiac) or peripheral (muscle) restrictions as a consequence of 
CKD/IS treatment. However, we believe sedentary lifestyle to be one of the main contributors
to the poor V02peak results. Firstly, most participants reported low levels of PA and a median 
of 7.5 hours of screen time per day. Secondly, the young adults (ped-tx) performed at 85% of 
the V02peak of healthy controls (paper III), relatively better than the tx children, and despite
longer exposure to CKD and IS treatment. This serves as an argument against CV sequela
being the main limiting factor of decreased CR fitness. However, this assumption relies on the
two tx groups (in paper II and paper III) both being representative for the eligible tx sample.
Pediatric tx recipients are, by virtue of persistent chronic kidney diseaseand exposure to
medication side effects, at risk for developing CV disease in adulthood. The importance of 
addressing hypertension, hyperlipidemia and excessive weight gain after tx is well recognized 
and established. In the group of 22 children the proportion of children with BMI >25kg/m2
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was twice that of the healthy Norwegian children (75), and the majority were hypertensive, 
demonstrating the burden of CV risk challenges in this group of tx children. Children with
two or three metabolic risk factors (IGT, hypertension and BMI z-score >2) had decreased CR 
fitness and PA compared to children with one or no risk factors. This finding must be 
interpreted with caution, as the sample size was small. Population studies in healthy children 
and adolescents have reported low levels of physical activity and/or CR fitness to be 
associated with single CV risk factors and clustering of CV risk factors (5;17;28;93) but this 
finding remains to be confirmed in larger studies in the pediatric renal tx population.
Reduced CR fitness in CKD/renal tx children and adolescents has been described in single 
reports for two decades (13;50;86;121;139;167), yet in the general guidelines on CKD 
management, no PA recommendations exist pre or post-tx, presumably due to the lack of  
prospective studies showing an exercise effect on CV risk factors and mortality. The ideal 
goal must be to preserve muscle strength/PA once progressive CKD is established, to prevent 
a sedentary lifestyle from developing and to counteract muscle wasting in advanced stages of 
CKD (44) further compromised by surgery and steroids post-tx (43). Implementing exercise 
programs for the first time while children are established on dialysis is a difficult task since 
the children with ESRD have been accustomed to inactivity and are fatigued (162). The 
Norwegian LD tx program involves no or minimal time on dialysis for the majority of 
children, offers an opportunity to reach children and caregivers and encourage PA before 
severe physical deconditioning has taken place. Weight bearing exercise should be 
encouraged and implemented in the general care of children with CKD before and after tx for 
a number of other potential benefits including attainment of peak bone mass, counteracting
weight gain after tx and not at least to enhance these children`s ability to participate in sports 
and play – a key to social interaction with peers.
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6.3 CR fitness in adults with a history of renal tx in childhood (paper III)
 As compared to adult transplanted subjects and healthy controls 
This is the first study presenting CR fitness data in adults with a history of predominantly LD 
organ tx in childhood. Providing long-term outcome data in young adults undergoing tx in 
childhood is of great importance to both the pediatrician and adult nephrologist in order to 
counsel patients and their caregivers, to initiate preventive measures and guide treatment 
strategies. Our purpose was to evaluate the impact of CKD from childhood on CR fitness, as a 
proposed indirect marker of CV function and physical functioning.
Our main finding was that the median V02peak level in adulthood was on average reduced by 
15 % in ped-tx survivors compared to HC despite exposure to CKD and IS treatment for 
many years. Thus, long-term exposure to IS treatment and CKD do not necessarily attenuate 
cardiorespiratory performance, but the interindividual variations ranged from excellent to very 
poor CR fitness. Echocardiographic studies using sensitive techniques have previously 
showed incomplete resolution of LVH and persistent diastolic dysfunction up to 5 years after 
pediatric renal tx (80;105). A current concern is that subclinical cardiac dysfunctions acquired 
in childhood will progress and limit physical functioning or even develop into congestive 
heart failure in adulthood (105). However, only two of the participants, as a consequence of 
their extreme obesity (BMI of 47 and 53 kg m-2), were classified within the V02peak
classification range for mild to moderate heart failure (i.e. V02peak < 20ml kg -1min -1) (168).
Another purpose was to put V02peak levels in former tx children into perspective, comparing 
two groups both subjected to renal tx and IS treatment but at different stages of life. We
compared ped-tx to a group of adults undergoing renal tx first time as adults (adult-tx). The 
large differences in final height between ped-tx and adult-tx/HC (Table 1, paper III) 
demonstrate the impact of long-standing CKD and steroid medication on the growing child. 
The height discrepancy probably contributed to significantly better exercise capacity (i.e. test 
duration) in the adult-tx since longer legs and fewer steps are less energy demanding. Due to 
inadequate power, no significant difference were found in V02peak (ml kg -1min -1) or (V02peak
FFM -1 min-1) between ped-tx and adult-tx participants. It was nevertheless reassuring that the 
difference in CR fitness was not larger, given the considerable longer exposure time of 
CKD/IS in the ped-tx participants.
In multivariate analysis, Hgb, FFM and duration time on the treadmill were the main 
predictors of V02peak. That is, FFM as a proxy to skeletal muscle function was a determinant 
for V02peak when adjusted for duration and Hgb. Neither FM nor tx participant group were 
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independent determinants for absolute V02peak, suggesting that interindividual physiological 
properties were more decisive for V02peak than the group affiliation. Whether long-term use of 
IS treatment/CKD restricts peripheral muscle function or cardiac function beyond that of 
physical inactivity remains to be determined.
6.4 Renal tx children and their caregivers’ perceptions of mental health and 
quality of life after renal tx (paper IV)
 Associations between somatic health variables and mental health and 
quality of life measures.
The primary aim of this study was to explore aspects of mental health, psychosocial 
adjustment and health-related quality of life (HRQOL) in children, adolescents and their 
caregivers compared to healthy controls and children with another severe pediatric chronic 
disease (ALL). The study showed that the tx children’s mental health, psychosocial 
adjustment and quality of life for most areas were significantly impaired on both self-reports
and proxy reports compared with healthy controls, and in several areas also lower compared 
to the ALL group. The impaired HRQOL in renal tx children and adolescents compared to 
healthy controls is consistent with findings from other studies using PedsQL (6;55;64;101).
Our study puts the impact of tx on HRQOL into perspective as compared to ALL – another 
severe pediatric chronic disease (134). The treatment protocol for ALL is 2.5 years and the 
follow-up is for most children and their parents confined to 5 years thereafter. The majority 
experience permanent remission. Tx children on the other hand must attend frequent hospital 
visits and take daily medications as lifelong reminders of a chronic disease.
In this study the “parents' perceptions” were represented by the mothers as they were the ones 
who accompanied their children to the investigation. While the mothers’ self-rated mental 
health was impaired compared to controls, it was reassuring that the mothers’ own overall 
satisfaction with life (HRQOL) did not diverge from that of the general Norwegian 
population. Although the numbers were small it is however worth noting that the mothers of 
children with a parental donor reported significantly more mental health problems and a 
tendency towards lower HRQOL than mothers of children receiving a kidney from non-
parental donors. Mothers are more often involved in the daily care of a chronically ill child 
compared to the father at the expense of work and personal life (23;174). The fathers are often 
underrepresented as research participants and tend to be more involved in other aspects of 
everyday life and they keep their worries to themselves (26;78). Recognition of psychological 
trauma among the parental donors is especially important to address as parental functioning in 
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general is a strong contributor to mental and psychological adjustments in children with 
chronic diseases (25). Moreover the results may act as an incitement to clarify the ethical 
controversies concerning the parental donorship. Further knowledge seems best provided by 
in-depth interviews involving the perceptions of both parents. Development of standardized 
psychosocial evaluations of parental donors is a suggested approach to protect donor interests 
(155).
The children’s own perceived mental health and HRQOL were related to BMI and CR 
fitness/V02peak, respectively, consistent with findings in adult renal tx (122;123). Several 
studies have reported separately on either low exercise capacity or reduced HRQOL in CKD 
and tx children (54;121;167) but no studies have to date explored the relation between an 
objective measure on CR Fitness (V02peak) and HRQOL in renal tx children. Regular physical 
activity, on the other hand, has been shown to have significant physical and mental health 
benefits, including reduced anxiety, improved body image, self-esteem, mood and quality of 
life(64;172). Our study points out the importance of an overall approach in the rehabilitation 
of these children; early interventions to promote weight control and to increase physical 
fitness must go hand-in-hand with psychosocial support.
6.5 Strengths of the studies
The major strength within our study was that all but three patients were transplanted at the 
same center (OUS Rikshospitalet). All patients benefited from the same surgical expertise and 
were followed by the era specific IS protocol. We were provided with accurate survival data, 
meticulously collected by the guardian of the Norwegian Renal Registry (Torbjørn
Leivestad). That is, no patients were lost to follow-up in terms of graft and patient survival 
data, so that a possible bias caused by informative censoring was therefore avoided. 
Moreover, as data were obtained from a single center we avoided the introduction of bias 
when comparing data from different centers. The registry data enabled identification of all 
available patients eligible for invitation to our CS study. The fact that all patients shared a 
childhood tx history from the same center as the study location may have reduced the drop-
out from the CS study.
Both children and adults in the CS studies participated in a comprehensive program including 
several investigations (papers II-IV, Table 1). Ped-tx participants were invited to volunteer for 
several reasons for this study besides exercise testing. If the study had involved only a
treadmill test we would have presumably only sampled a group that was physically fitter and 
more motivated than this patient population as a whole. 
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We used the maximal treadmill exercise test to assess CR fitness – generally regarded as the 
“gold standard” in assessing V02peak. Treadmill testing has been a well-established procedure 
at our Pediatric Department for more than a decade and includes a test lab with experienced 
test leaders, a test protocol developed and validated for children with a chronic disease (74)
and not least, it has undergone substantial research activity.
6.6 Limitations
6.6.1 Study design
Assessing possible causal relationship in clinical studies is always an important purpose. The 
randomized controlled study (RCT) ranks highest in the hierarchy of evidence as it, through 
the randomization process, minimizes the risk of confounding (158). It is the gold standard 
when investigating the effect of a health intervention or treatment. However, as our overall 
purpose with the study was mainly a descriptive one, measuring the occurrence of graft loss 
and patient outcomes, the observational (cohort) study was a more suitable approach (paper I).
It would have been considered unethical, unpractical and inappropriate to randomize children 
with ESRD to either LD organ or DD organ recipients. Observational studies have less 
potential to determine causal relations than RCT`s, but confounding can be reduced through 
stratification and regression analyses.
The cross-sectional study design (papers II-IV) is well suited for descriptive purposes and for 
the generation of hypotheses but restricts interpretation of causal relations. Accordingly,
whether lower CR fitness was a consequence of clustering of metabolic CV risk factors or 
vice versa (paper II) could not be determined with this design. Furthermore, we could not 
state with certainty whether low CR fitness entailed low HRQOL, or whether low HRQOL 
contributed to impaired physical activity and therefore lower V02peak (paper IV). We 
acknowledge that a prospective exercise study, incorporating the temporal aspect of exposure 
and outcome, would have been a more appropriate design to answer whether better CR fitness
reduces clustering of CV risk factors and improves HRQOL.
6.6.2 Selection bias, information bias and confounding
The internal validity of an epidemiological study can be affected by random error and 
systematic errors. Random errors (variation in the data due to measurement imprecision) can 
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be reduced by increasing the sample size. Systematic errors are unaffected by sample size, but 
affects the validity of the study and includes selection bias, information bias and confounding 
(30).
The CS study provides a snap-shot of the prevalence of risk factors in a population. However, 
estimates of prevalence are vulnerable to selection bias. A selection bias arises when factors 
affect study participation in such a way that the outcomes measured are not representative for 
the non-responders or the population as such. For example, one might select a sample from a
sub-population of individuals of a particular age or condition which are not the same as in the 
population of interest. As the main study aim (papers II and III) was to assess CR fitness, an 
unavoidable selection bias was introduced by the exclusion criteria (excluding comorbidities 
such as movement disorders or blindness) affecting the generalizability to the frame 
population of renal tx children and adults (reduced internal validity). 
In paper II we claimed to have a representative sample of eligible tx children and adolescents. 
However, non-participants were older than participants although no other differences in basic 
demographics were found. We assume that age per se was not the most important factor
governing CR fitness level, so given there were no other differences between participants and 
non-participants we regard our sample as representative for the eligible population of renal tx 
children. In paper IV a respondent (selection) bias was introduced by the mothers being the 
only “spokesperson” for the parents. Before we can conclude on parental opinions we must 
also include the fathers’ perceptions.
Use of questionnaires to collect information on physical activity has obvious limitations. The
PA questionnaires used were developed for healthy children and adults and were not 
specifically validated for the group of renal tx recipients. To recall the intensity, duration and 
frequency of PA the previous week is difficult. The judgment of intensity level is highly 
subjective, and therefore prone to misclassification of subjects into the wrong PA intensity 
categories (misclassification bias). A Swedish validation study of IPAQ short format (used in 
paper III), pointed out that self-reported time spent in PA was overestimated as compared to 
accelerometry (7). The PA questionnaire used for children and adolescents (paper II) had only 
been validated for healthy 9-10 year old and 13-14 year old children and not for the whole 
age-span of participants of our study (>14 years of age), limiting its validity in older 
adolescents. The activity questions did not include information on type of PA, and 
participation in physical education during school-time was not included. Moreover, in
children, the sporadic and intermittent nature of the physical activities make it difficult to 
capture reliable data via self-report (160). Lastly, in the validation study of the children`s 
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questionnaire, the correlation coefficient between MVPA and the activity monitor was low to 
moderate (r=0.27-0.48).
Confounding implies that the effect of an exposure on the outcome is mixed with the effect of 
another variable leading to spurious conclusions (153;171). Allometric scaling may alleviate 
the confounding effect of differences in body mass on V02peak but does not fully compensate 
for differences in body weight and size between individuals. It is possible that excessive 
weight (BMI z-score > 2) mediated or confounded the association between reduced CR 
fitness and the clustering of CV risk factors. 
6.6.3 Interpretation of V02peak (papers II-III)
The conventional presentation of V02peak is relative to body weight (i.e. ml kg-1 min-1), and has 
an advantage when reporting results compared to other exercise research. However, dividing 
absolute V02peak (l min -1) by body weight has been questioned as it leads to overestimation of 
V02peak in lean subjects and underestimation of V02peak in obese subjects since changes in
body weight and V02peak (l min -1) are not linearly related (171). Allometric scaling (AS) is a 
method when V02peak is adjusted to body weight raised to a given power different from unity 
(e.g. ml kg -0.67min-1). AS may alleviate the confounding effect of differences in body mass 
(129) on V02peak. However, the exponent of 0.67 used in paper II was theoretically based on 
the surface law (surface area = volume 2/3) applied for the reference group of healthy children 
(163), and not derived for the tx children in particular. In order to derive specific exponential 
factors for tx children a larger sample size would have been needed. Moreover, the tx children 
could differ in more than one scaling variable (e.g. gender and age) not captured by a 
universal exponent (8;29;164). Expressing V02peak divided by fat free mass (V02peak FFM -1
min-1), i.e. relative to the metabolically active tissue during exercise, has been suggested as an 
appropriate approach (51) and was the method of choice in paper III. Indeed, the difference in 
V02peak between overweight/ obese in our study was no longer significant when analysed in 
terms of FFM. However, it has been argued that V02peak ratioed to FFM could result in 
inappropriately high values for obese subjects (as the numerator is increased and denominator 
decreased), and thus “overcorrects” the effect of excess fat weight on the ability to do 
exhaustive work (46).
If the purpose is to evaluate the unadjusted or total V02peak on CV morbidity in a prospective 
study, V02peak in ml kg-1 min-1 is suggested as a proper choice. However, if one is interested in 
the direct/adjusted effect of CR fitness on CV outcome, one has to adjust for differences in 
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body composition/ body dimensions as excessive weight could be a confounder on metabolic 
health outcome.
6.6.4 Other methodological limitations
The available number of participants eligible for recruitment was limited as pediatric renal tx 
is a rare event. Accordingly, the number of participants in the CS studies (papers II-IV, total 
n=69) were small and the findings have to be interpreted cautiously. In addition, reporting a 
single center experience may have limited external validity; as patient selection, treatment 
protocols and culture vary between centers/countries. Moreover, the heterogeneity of primary 
renal disease, the duration of CKD prior to tx not accounted for, differences in graft function 
and variable IS regimens could have contributed to the variability in outcomes that limited the 
ability to disclose significant differences between groups (136). Indeed, the standard deviation 
score in V02peak (paper III) was larger than expected and contributed to a reduction in the 
statistical power. 
Death by cardiovascular cause was based on the diagnosis given in the registry reports and on
information obtained from the medical records (paper I). For several of the “CV deaths”,
autopsy reports were either lacking or inconclusive. Consequently we cannot exclude the 
possibility that some of the sudden deaths were caused by arrhythmias secondary to 
electrolyte disturbances and therefore misclassified as a cardiovascular cause. 
Today, a biopsy will be performed early on the suspicion of an AR or chronic rejection. 
However, biopsies were not a tradition during the first two decades of renal tx in Norway. AR 
and chronic rejections were clinical diagnoses based on increasing levels of s-creatinine (and 
regarding AR, other clinical signs of rejections). Moreover, when a biopsy was performed the 
result was not always unambiguous. Thus the proportion of AR and chronic rejections could 
therefore have been overestimated/ misclassified based on the data obtained.
ABPM measurements were for most participants (paper II) performed during the two-day
scheduled program and not in a typical daily life situation. It is possible that this procedure 
reduced the validity of the recordings performed in a “hospital environment” influenced by 
unconscious stress factors (conditional learning from previous history).
We concluded from our sample of renal tx children that they in general performed poorly on 
the treadmill tests and reported low levels of PA. Several aspects could contribute to
overestimating the difference in V02peak between the tx children and the healthy reference 
group (paper II). Firstly, it is possible that the reference population was fitter than the child 
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population in general as they were recruited on a voluntary basis. Secondly, it is challenging 
to motivate sedentary children with a chronic disorder to perform at maximal effort, since 
they are unused to strenuous exercise – as demonstrated by significantly lower RER in tx 
children than the reference population; thus a true maximal effort was probably not achieved 
in all tx children. Thirdly, none of the children in the reference group were overweight 
(compared to 1/3 of the pediatric renal tx). Finally, renal tx children were significantly shorter 
than controls. It is possible that using their height age would have been a more appropriate 
approach than chronological age when comparing V02peak results to the healthy group of 
children, as has been proposed by Schaefer et al (170).
The mean difference in V02peak between ped-tx and adult-tx was 3 ml kg -1min -1 and this 
difference was not statistically significant (paper III). Unfortunately, as we were limited by a 
small sample size our study was underpowered to exclude there being a statistically 
significant difference in CR fitness between ped-tx and adult-tx, but the size of this difference 
is smaller than 3 ml kg -1min -1. Thus we cannot rule out making a type II error (fail to reject 
the null hypothesis when it in fact was false).
The use of transplant-specific HRQOL instruments in addition to generic HRQOL measures 
could have provided more useful information in a group of children with disease specific 
challenges (paper IV) (176). Moreover, the questionnaires were unable to identify the specific 
problems encountered by parents and the child leading to reduced quality of life.
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7. CONCLUSIONS AND CLINICAL IMPLICATIONS
Children with ESRD are one of several groups of children with a severe chronic health 
condition whose survival prospects have increased dramatically due to advances in medical 
care and treatment. As outlined in this thesis, tx is no cure from chronic kidney disease or 
ensuing comorbidities. Providing knowledge on outcome after renal tx in childhood is 
important so as to allow guidance on treatment decisions and to counsel children, parents and 
adult survivors. 
We have shown that long-term patient survival can be achieved for most children after renal 
tx and the best graft survival is obtained with LD organs. Pre-emptive tx and avoidance of 
long-term dialysis remains a key strategy in reducing exposure to CV risk factors in children 
with ESRD (90). The major challenge remains to further improve long-term graft survival, as 
preserving graft function is the cornerstone also for minimizing the associated CV risk 
factors. In this study the majority of tx participants had advanced kidney failure (CKD stage 
3-4 ranging from 58-77%, paper III and II, respectively). Close monitoring of the graft 
function including (protocol) biopsies and pharmacokinetic monitoring are possible tools to
slow the decline in GFR. The perfect combination of IS agents for maintenance of graft 
function while minimizing nephrotoxicity demands individually tailored immunosuppressive 
protocols, including corticosteroid avoidance in selected patients. The effects from steroid 
avoidance includes improved linear growth and reduction in CV risk factors (12).
Our study has contributed to increased awareness of the importance of enhancing physical 
functioning in renal tx children, recognizing that physical functioning, body habitus and 
quality of life are related measures. Early interventions to promote weight control post-tx, and 
proper monitoring, treatment and reassessment of hypertension are crucial to alleviate the 
decline in graft function and reduce CV risk. We have also shown that not just physical but 
mental health problems and psychosocial dysfunction can persist several years after tx, 
affecting the child’s quality of life and parental functioning. Optimal treatment and follow-up
of tx children and their parents require close collaboration between pediatricians and 
psychosocial experts including interventions to promote physical activity, healthy nutrition
and coping strategies.
Long-term exposure to IS treatment and CKD did not necessarily attenuate cardiorespiratory
performance in adults below that of healthy controls, but the interindividual variations ranged 
from excellent to very poor CR fitness. Exercise testing is underappreciated as a global 
outcome measure in renal tx patients. Not only can exercise tests identify those that can 
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benefit the most from exercise in a physical functioning/ quality of life point of view, but the 
level of CR fitness is a plausible prognostic factor for morbidity and mortality, as has been 
shown for the healthy population and patients with established CV disease. Exercise should 
be encouraged and included in the medical care of tx recipients irrespective of age.
Proposed PA strategies in children with CKD/tx:
1. Recommendations for sustaining physical activity are suggested and included in the 
existing guidelines on the treatment of CKD as a first step to acknowledging the importance 
of maintaining physical activity as chronic renal function deteriorates.
2. Physicians and health care personnel must encourage and inform children and their parents 
of the significance of maintaining PA, as physical functioning and quality of life are 
interconnected.
3. For those transplanted, an individually developed exercise education program should be 
started during the first three months when the child and caregiver are followed up at the tx 
center, and continued with local physiotherapists according to individual needs.
4. A dietician should be involved post-tx to help establish good nutritional habits to avoid
excessive weight gain, particular for those predisposed.
5. At the regular outpatient visits PA participation in school and leisure time should be
inquired about and encouraged. 
6. Professional mental health guidance, which includes developmental and family perspective 
advice should be offered routinely to the tx patient and their parents. 
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8. FUTURE RESEARCH
First of all it could be worthwhile to review the outcome of pediatric renal tx again in ten 
years time to evaluate whether the impact of the current knowledge and progress in treatment
leads to improved graft survival and physical functioning.
In this thesis we were more than once faced with inadequate power to answer the research 
questions, and the CS design restricted interpretation of causal relations. In the field of 
pediatric nephrology research is generally hampered by small sample size and the subsequent
lack of power. To overcome these limitations one approach is to increase sample size through
multicenter studies (for example through a Nordic research network). 
No exercise intervention study has to date been performed in children with CKD prior to or
post-tx. Thus, a proposed future study design may be a randomized controlled trial with 1-2
years exercise intervention compared to usual care, either in children with CKD or post-tx.
Possible endpoints could be a) improvement in CR fitness/ muscle strength, b) body 
composition changes and c) HRQOL development. Another under – researched field is the 
impact of weight bearing exercise intervention programs on bone mineral accrual. Peak bone 
mass acquisition during adolescence is in general a key determinant of the lifetime risk for 
osteoporosis and fractures. Renal tx patients, and in particular tx children who are exposed to 
CKD and steroids from childhood have an increased risk for osteoporosis. Exercise 
intervention studies are also needed in adult survivors of childhood tx to study whether the 
functional response to exercise programs is the same as in healthy subjects, and to evaluate to 
what extent cardiac or peripheral muscle function is altered after many years on IS treatment.
The prognostic value of CR fitness in this category of ‘at risk’ individuals on CV morbidity, 
remains to be evaluated in a longitudinal study. Outcome variables may include 
hospitalizations, CV events and even death. However, such a design is time consuming and 
multicenter studies may once again prove necessary to capture enough events.
Graft survival time remains the most traditional outcome variable to rate the success of a tx 
program. From the children’s and parents’ point of view the degree of rehabilitation towards 
over-all functional normality may be at least as important. To obtain further insight into the 
specific problems and range of opportunities encountered by children and their caregivers
prior to and after tx further qualitative research is warranted.
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10. ERRATA
Paper I 
The p-value (p=0.02) in Figure 2 (page 765) is incorrect, the correct p-value is p=0.008
(unadjusted log rank test between LD and DD graft survival).
Paper II 
Methods/biochemistry, page 2: The phrase “Metabolic syndrome was defined when three or 
more of the following criteria  were fulfilled…..” should have been rephrased to: ”Metabolic 
syndrome was defined when three or more of the following criteria were fulfilled, modified 
after Weiss et al…”
Weiss et al used 95th percentile to define dyslipidemia, while we chose to use P-HDL < 
40mg/dl (<1.03mmol/l), P-Triglycerides >150mg/dl (#$%
	

	
dyslipidemia. 
Results, page 4:
“Only 3 participants obtained V02peak within the expected range (i.e. V02peak z-score 2)”, 
should have been V02peak z-score -2. The same type of error occurs at the same page: 
“None of the children were underweight in terms of BMI z-score < 2” at TX, should have 
been changed to: “None of the children were underweight in terms of BMI z-score < -2.”
Paper III
Reference 23 is incorrect, the correct citation is:
Morris JF. Spirometry in the evaluation of pulmonary function. West J Med 1976 
Aug;125(2):110-8.
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Abstract Our objective was to assess the mental health and
health-related quality of life (HRQOL) in children and their
parents after renal transplantation (TX) compared to healthy
controls and children with acute lymphoblastic leukemia
(ALL) and to identify possible health status variables
associated with impaired mental health and HRQOL.
Thirty-eight TX children with a median age of 13 (range
3–19) years were investigated. Mental health was assessed
by the Pediatric Quality of Life Inventory (PedsQL) 4.0
Generic Core Scales and the Strength and Difficulties
Questionnaire (SDQ-20). Each mother’s own mental health
and QOL were assessed by the General Health Question-
naire (GHQ-30) and the Quality of Life Scale (QOLS).
Forty children with ALL [median age 11 (8.5–15.4) years]
and 42 healthy children [median age 11 (8.9– 15) years]
served as controls. Treadmill exercise results from 22 of the
38 patients were included in the analysis. TX children
showed significantly higher levels of mental health prob-
lems and lower HRQOL at 2 to 16 years after transplan-
tation compared to both control groups. Body mass index
and maximal oxygen uptake (n=22/38) were significant
predictors of child mental health (SDQ) and child QOL
(PedsQL), respectively. Based on these results, we suggest
that rehabilitation after TX should include a focus on
physical activity and QOL to reduce interconnected
physical and psychological morbidity in kidney TX
children.
Keywords Childhood kidney transplantation .
Mental health . Quality of life . Body mass index .
Cardiorespiratory fitness
Introduction
The Norwegian era of renal transplantation (TX) in children
started in 1970 [1]. The TX option has resulted in a
dramatic increase in the survival of children with end stage
renal disease (ESRD) and has been the treatment of choice
ever since its introduction. In Norway, 84% of pediatric
renal transplants are provided from living related donors
(LD), mostly parents (74%). The pre-transplant dialysis
time is short (median 3 months), and 50% of trans-
plantations are performed preemptively [1]; this provides
good premises for graft survival and ensures a better quality
of life (QOL) pre-transplant.
Over the decades, the introduction of more potent
immunosuppressive medication and better pre- and post-
transplant care have led to improvements in graft survival
worldwide [2, 3]. In addition, increased surgical experience
has made it possible to include infants (<2 years of age)
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with ESRD in the TX program. The initial aim of TX has
evolved from prolonging life to achieving long-term
survival and enhancing the QOL to close to that of the
age-matched general population.
However, both progressive chronic kidney disease
(CKD) and the post-transplant period with mandatory
immunosuppressive medication (IM) are associated with
adverse physical and psychological consequences. This
includes adverse effects on linear growth, weight gain,
osteoporosis, reduced physical functioning, hypertension,
reduced glucose tolerance and hyperlipidemia [4, 5].
Rejection of the graft followed by graft loss is a constant
threat for both the child and caregiver. In the long run,
children are at higher risk for cardiovascular disease,
infections and malignancies, all of which contribute to
increased long-term morbidity and mortality. Finally, the
pre-, peri- and post-operative stress associated with renal
transplantation per se and the fact that children during a
transplantation are often isolated from their peer groups for
long periods of time may increase the risk for mental and
psychosocial disturbances, predisposing for a reduced QOL
both for the child and the parents.
Previous research in children with advanced CKD until
the need for renal replacement therapy has generally
confirmed an increased risk of impaired mental health,
psychosocial functioning and QOL [6–9]. However, most
studies of psychosocial and QOL effects of CKD have
included children with a wide variety of somatic status, and
research has often failed to separate out the results by type
of somatic status. Another challenge is that studies are
performed at different stages of diagnosis or treatment and
at various ages, with the patients having different develop-
mental levels and psychological needs.
Earlier reports have stated good long-term QOL and
psychosocial outcome after kidney TX during childhood
[10–12]; however, these studies were conducted with adult
patients and based on non-standardized questionnaires.
There are only a few studies on health-related QOL
(HRQOL) in CKD children and adolescents after kidney
TX [8, 9, 13–22]. Most of these studies differ in their
methodology and generally present conflicting results.
Studies on mental health and psychosocial functioning
after kidney TX are even scarcer and diverge in their
findings. Some indicate no differences between the trans-
plant recipient and the healthy control [14, 23, 24], whereas
others report an increased risk for maladaptive psychosocial
sequels with emotional disturbances, such as anxiety, fear,
depression, anger, withdrawal and symptoms of posttrau-
matic stress [15].
There is no controversy on the superiority of LD organ
in terms of graft survival. However, little is known on the
extent to which the LD graft benefit translates into a better
QOL for the parent and child. We hypothesized that LD
organ TX would have a more favorable QOL outcome for
the child and parent relative to other severe pediatric
chronic diseases. We also assumed that QOL issues are
related to objective measures of physical functioning, as has
been shown in studies of adult renal TX [25]. Therefore, the
primary aim of this study was to explore aspects of mental
health and HRQOL in children, adolescents and their
caregivers after renal TX and compare these to those of
healthy controls and children with another severe pediatric
chronic disease, namely, acute lymphoblastic leukemia
(ALL). The second aim was to investigate the potential
associations between health status variables and mental
health, psychosocial functioning and HRQOL.
Patients and methods
Subjects
All renal transplanted children in Norway undergo TX at
the same University hospital and pay yearly visits, until
transition to adult care at about 18 years of age. From this
cohort, children and adolescents aged 2–19 years, trans-
planted between 1993 to 2006, were invited to participate in
a cross-sectional study involving a 2-day comprehensive
medical investigation program. Participants were enrolled
from May 2008 to June 2009. Inclusion criteria were
functioning graft for at least 1 year. Of the 50 patients asked
to participate, 38 agreed [76%; 13 (34%) girls, 25 (66%)
boys; median age 13 (range 3–19) years]. Parental
information was obtained from 32 mothers [median age
40.5 (25–51) years]. Average time since first transplantation
was median 4.9 (2–16) years. All patients except for one
received prednisolone daily (n=23) or every other day (n=
14) [median 0.08 (0.03–0.18) mg/kg/day]. There were no
significant differences in sex, renal function, or proportion
of LD recipients between the participants and non-
participants, but non-participants (n=12) were significantly
older than the participants [median age 16.9 (6–20) years].
Data regarding the total patient cohort demographics,
primary renal disease, pretransplant dialysis treatment,
donor issues and number of transplants have been pub-
lished previously [1].
A subgroup of the participants (n=22/38) had previously
been tested on the treadmill [26]. Of the 38 participants,
children <8 years of age (too young for test requirements;
n=7) and patients with orthopedic limitations (n=5) were
excluded. Two adolescent girls eventually refused to be
tested due to motivational problems and two adolescent
boys ended the test before maximal effort was attained;
these data were not included in the exercise test study.
The 38 transplanted children and adolescents were com-
pared to 42 healthy controls [median age 11 (range 8.9–15.0)]
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recruited from two elementary schools and two junior high
schools from both urban and rural areas in the middle part of
Norway and to a group of 40 children with ALL [median age
11 (8.5–15.4)]. The control and comparison groups which
serve as reference material for the patients in the present study
were studied in a previous study and are extensively
elaborated on in the papers of Reinfjell et al. [27, 28]. There
were no significant differences between the three groups in
terms of gender, age or socio-demographic characteristics,
such as family composition, parental age and educational
level, community, home and economy.
The baseline socio-demographic characteristics for the
patients and the control and comparison groups are shown
in Table 1.
Measures
Anthropometrics and renal function
Height was measured to the nearest 0.1 cm using a
stadiometer. Weight was measured to the nearest 0.1 kg
on a digital scale. Body mass index (BMI) was calculated
as kilograms per square meter. Anthropometric data were
converted to standard deviation scores (BMI z score and
height z score) based on Cole’s LMS method [29].
Overweight and obesity were defined according to BMI
cut-off limits proposed by The International Task Force
(isoBMI >25 and isoBMI >30, respectively) [30]. Glomer-
ular filtration rate (mGFR) was measured using a single
intravenous injection of iohexol with blood sampling after 3
h as previously reported [26].
Exercise testing
Cardiorespiratory fitness (CR Fitness) was defined as
maximal oxygen uptake (V02peak, in ml kg
-0.67min-1) and
was assessed with an incremental treadmill test until
exhaustion. The treadmill test procedure and the evaluation
criteria for a maximal test have been described in more
detail in a previous report [26].
Children’s mental health, psychosocial functioning
and QOL
The Strength and Difficulties Questionnaire (SDQ) was
used to assess the mental and psychosocial health in
children and adolescents [31]. The SDQ is a brief
behavioral screening questionnaire consisting of 25 items
in addition to a supplement on the impact of the difficulties
for the child and family. Each item uses a three-point
ordinal Likert format and can be answered with: “not true”,
“somewhat true” or “certainly true”, rated 0–2 for nega-
tively worded items and rated inversely 2–0 for positively
worded items. In this way, for all items, higher scores
indicate more problematic attributes. There are five sub-
scales: Emotional symptoms, Conduct problems, Hyperac-
tivity, Peer problems and Prosocial behavior, with the first
four adding up to the Total Difficulties Score. Subscores are
generated for each subscale (range 0–10). A total difficul-
ties score of ≥19 defines symptom "caseness" according to
Goodman (www.sdqinfo.com) and adjusted to Norwegian
cut-offs [32]. As such, a symptom score >90 percentile
predicts a substantially raised probability of being diag-
nosed with a psychiatric disorder, and a score of 16–18 is
defined as “borderline”, i.e., symptom score within percen-
tile 80–90. The prosocial subscale measures the child’s
ability to act prosocially independent of the difficulties
measured by the other subscale. The SDQ also includes a
brief impact supplement where the respondent is asked
whether he thinks he has a problem and, if so, inquires
further about chronicity, overall distress, social impairment
related to the family, friends, learning situation and leisure
activities and, lastly, about the burden on the environment.
The impact questions have four response categories which
correspond with a point scale 0–0–1–2. A total impact score
of ≥2 defines impact "caseness", i.e. having variable
functioning with sporadic difficulties or symptoms in
several but not all social areas, and a score of 1 is defined
as borderline, i.e. having difficulty in a single area but
generally functioning pretty well. There are similar versions
for parents. The SDQ shows satisfactory reliability and
validity [31, 33]. Normative data based on a large
representative Norwegian sample exist [32].
The Pediatric Quality of Life Inventory (PedsQL) 4.0
[34–36] was used to measure HRQOL in children and
adolescents [37]. The 23-item PedsQL, version 4.0 Generic
Core Scales, can be grouped into four domains of HRQOL:
(1) Physical functioning (8 items), (2) Emotional functioning
(5 items), (3) Social functioning (5 items) and (4) School
functioning (5 items). The Generic Core Scales are comprised
of a child self-report, with included ages of 5–7, 8–12 and 13–
18 years. Parent proxy-report includes ages 2–4, 5–7, 8–12
and 13–18 and assesses parents’ perceptions of their child’s
HRQOL. The items for the self-report and proxy-report are
essentially identical, differing in developmentally appropriate
language and first-or third-person tense.
The instructions ask how much of a problem each item
has been during the past 1 month. (0=never a problem; 1=
almost never a problem; 2=sometimes a problem; 3=often
a problem; 4=almost always a problem). Subjects are
requested to rate how many problems they experienced
during the past month with health (e.g. I hurt or ache),
activities (e.g. It’s hard for me to run) or feelings (e.g. I feel
afraid or scared).
Items are reverse-scored and linearly transformed to a 0–
100 scale (0=100, 1=75, 2=50, 3=25, 4=0) so that higher
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scores indicate better HRQOL. Scale scores are computed
as the sum of the items divided by the number of items
answered (this accounts for missing data). In addition to the
four subscales, a Total Summary Health score (23 items)
can be computed. A Psychosocial Health Summary score
(15 items) can be computed as the sum of the items divided
by the number of items answered in the Emotional, Social,
and School Functioning Subscales, and a Physical Health
Summary score (8 items) is the same as the Physical
Functioning subscale. The PedsQL 4.0 has achieved
excellent reliability for the Total Scale score (0.89), and
has been shown to differentiate between healthy children
and children with chronic health conditions [38, 39].
PedsQL as a generic measure allows for the assessment of
common dimensions among both healthy and chronically ill
children as well as for comparisons across populations [40].
PedsQL has been shown to be an appropriate assessment
tool for both healthy children, children with ALL [27] and
children with CKD [8, 9, 13]. A Norwegian version of the
PedsQL 4.0, concerning psychometric properties, is pre-
sented in more detail in an earlier work [41]. The PedsQL
has shown satisfactory psychometric properties [35, 41].
Maternal mental health and quality of life
The General Health Questionnaire (GHQ) [42] is a widely
used screening instrument for assessing the presence of
distress, psychopathology and overall well-being in adults,
Socio-demographic characteristics TX (n=38) ALL (n=40) Healthy (n=42)
Gender, n (%)
Girl 13 (34) 21 (53) 21 (50)
Boy 25 (66) 19 (47) 21 (50)
Age at study (years)
Mean ± SD 12.2 ± 4.0 11.8 ± 1.9 11.8 ± 1.9
Median (range) 13 (3–19) 11 (8–15) 12 (8–15)
Treatment
GFR (ml/min/1.73 m2), median (range) 51 (22–95) - -
Age at TX/diagnosis (ALL) in years, median (range) 1.1 (0–15) 3.1 (0–7) -
Years since TX/treatment (ALL), median (range) 4.9 (2–16) 7.1 (4–12) -
Parental characteristics n=32
Family composition, n (%)
Both parents 25 (78) 31 (77) 29 (70)
Single parent 7 (22) 9 (23) 13 (30)
Age in years, median (range)
Mother 40.5 (25–51) 40.0 (30–55) 40.0 (31–52)
Father 43.0 (28–58) 43.0 (32–58) 43.5 (34–72)
Education in years, median (range)
Mother 13.0 (8–18) 14.0 (10–19) 13.0 (9–19)
Father 12.0 (9–17) 14.0 (10–20) 13.0 (10–19)
Community, n (%)
Urban 16 (50) 15 (37) 18 (43)
Rural 16 (50) 25 (63) 24 (57)
Home, n (%)
Own house 25 (78) 36 (90) 39 (93)
Own apartment 3 (9) 3 (8) 3 (7)
Renting apartment 4 (13) 1 (2) 0 (0)
Economy, n (%)
Very satisfying 14 (44) 27 (67) 21 (50)
Good 16 (50) 8 (20) 21 (50)
Poor 2 (6) 5 (13) 0 (0)
Mothers mental health/QOL n=34 n=37
GHQ case score (mean ± SD) 2.1 ± 4.8 3.3 ± 6.7 1.2 ± 3.3
n (%) cases; cut-off: 5–30 6 (18.8) 6 (17.6) 2 (5.4)*
QOLS score (mean ± SD) 90.4 ± 10.0 - -
Table 1 Socio-demographic
characteristics of 38 children
with kidney transplantation
(TX) and their parents compared
to children with acute lympho-
blastic leukemia (ALL) and
healthy controls. Treatment
variables are reported for the
children with TX and children
with ALL
*Difference between TX and
ALL/healthy respectively is
significant at the 0.05 level
(two-tailed)
TX, Transplantation (children
with kidney transplantation);
ALL, acute lymphoblastic
leukemia; SD, standard devia-
tion; GFR, glomerular filtration
rate; GHQ, General Health
Questionnaire; QOLS, Quality
of Life Scale
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showing acceptable and well-established reliability and
validity. The GHQ includes both positive and negative
questions, and the short version GHQ-30 contains 30 items
covering symptoms considered to reflect psychological
distress and well-being. Each question is answered on a
four-point scale. The answers to each item may be treated
both as a “Likert” score recommended for use in longitu-
dinal studies when measuring change and have weights
assigned to each position (0–1–2–3), with a possible scale
of 0–90, and as “Case” score, with weights (0–0–1–1) and
possible range of 0–30. When using the GHQ-30 as a
screening instrument for overall psychological distress, as
in this study, the Case-scoring has proved to provide
acceptable values for sensitivity and specificity [43]. A
conventional cut-off was used; scores of ≥5 were defined as
“cases”.
The Quality of Life Scale (QOLS) [44] is a questionnaire
measuring an adult’s overall satisfaction with life based on
different life domains. It belongs to the category of global
or overall QOL tools. The QOLS is a short questionnaire
and contains additional information on areas not usually
included in HRQOL measures, such as independence,
material comfort, work satisfaction, recreation, etc. This
scale has been widely used in health services research and
has established psychometric properties and Norwegian
norms [45]. The QOLS is a 16-item self-report and domain-
specific instrument exploring factors such as physical and
material well-being, personal development, relationships
with others, participation in social, community and civic
activities and recreation. The adults are asked to rate their
present level of satisfaction with the above-mentioned
factors on a seven-point scale. The scale is scored by
adding up the items to obtain a total score with possible
range 16–112. A higher score depicts a better quality of life.
Statistics and ethics
Continuous variables are presented as the mean ± the
standard deviation (SD) or if skewed as the median and
range. Categorical variables are given as proportions and
percentages. Differences between independent groups with
regard to continuous variables were quantified with the
two-sample t test, or with the Mann–Whitney–Wilcoxon
test in the case of severe skewness in the data. Categorical
variables were compared between groups using the chi-
squared (χ2) test or Fisher’s exact test for small samples.
The strength of associations between normally distributed
continuous variables was measured using Pearson’s corre-
lation coefficient or Spearman’s correlation coefficient
when the variables had a skewed distribution.
Forward linear regression analysis was used to analyze
possible explanatory variables as predictors of mental
health and QOL [46]. Variables with p < 0.05 from the
univariate analysis were included in the multiple linear
regression model. A careful check of the model assump-
tions, including an investigation of residual plots, did not
reveal any violation of the assumptions.
All analyses were performed in SPSS ver. 16.0 (SPSS,
Chicago, IL). We chose a 5% statistical significance level.
Written informed consent was obtained from patients
and/or their parents if less than 16 years of age prior to
study start. The study protocol was approved by the
National Committee for Research Ethics and carried out
in accordance with the Declaration of Helsinki.
Results
Thirty-four children (89%) received a kidney from a LD,
with 27 (79%) being donated from parents (13 mothers, 14
fathers), five from grandparents, one from a sibling and one
from an aunt.
Anthropometrics and exercise testing
Thirteen patients (34%) were overweight (n=8) or obese
(n=5); the proportion of overweight patients among the
treadmill participants was 36% (8/22). Eleven patients
(29%) were growth-retarded (height z score <−2). In the
treadmill participants, median V02peak was 66% (range 36–
97%) of the expected values compared with the healthy
controls (n=196). Only three participants obtained V02peak
within the expected range (i.e. V02peak z score ≥−2)
(previously published data [26]).
Child mental health, psychosocial functioning and QOL
The SDQ and PedsQL for TX children, the group of ALL
and the healthy controls are presented in Table 2.
Both the TX children and their mothers reported
significantly higher SDQ scores than the healthy controls
in terms of total difficulties, emotional problems and peer
problems with more total difficulties caseness and impact
score caseness. Relative to the healthy controls, the mothers
reported even significantly higher SDQ scores regarding
conduct problems and hyperactivity problems but lower
prosocial behavior. Compared to the ALL group, the TX
children and their mothers reported significantly higher
SDQ scores regarding total difficulties, emotional problems
and impact score, with more total difficulties in terms of
caseness. The SDQ scores for the healthy controls are not
significant different than the SDQ norms or reference
values from the general Norwegian population [32].
Both the TX children and their mothers reported
significantly lower HRQOL scores on all PedsQL items,
with the exception of emotional functioning, than the
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healthy controls and the ALL group. The SDQ and PedsQL
scores were not associated with age, sex or years since the
TX date. When the patients were classified into age groups
according to the developmental perspective, i.e. 3–12 years
and 13–18 years, we found no significant differences in the
SDQ and PedsQL scores between the two groups. Further-
more, there were no significant differences between the
scores of the children and the scores of their mothers on the
SDQ or PedsQL.
Maternal mental health and QOL
The GHQ and QOLS for the mothers of TX children, the
group of ALL and the healthy controls are presented in
Table 1. The mothers of TX children reported significantly
more mental health problems (GHQ-case) than the mothers
of healthy controls, but their scores were comparable with
those of the ALL group. The QOLS scores in the control
group are not significant different than QOLS norms or
Mental health and quality of life scales TX (n=38) ALL (n=40) Healthy (n=42)
PedsQL child self-report n=30
Total score 69.10 (17.98) 81.70 (12.56)*** 88.98 (7.57)***
Psychosocial health 67.03 (18.05) 79.27 (13.99)** 87.22 (9.20)***
Physical functioning 74.89 (17.01) 86.25 (12.13)** 92.26 (6.45)***
Emotional functioning 69.48 (15.81) 75.13 (18.69) 83.21 (12.68)***
Social functioning 73.71 (21.54) 86.00 (14.11)** 92.50 (7.67)***
School functioning 63.10 (17.75) 76.63 (16.38)** 85.95 (12.98)***
PedsQL mother proxy-report n=32 n=36 n=38
Total score 68.37 (19.17) 79.42 (12.50)** 89.62 (10.26)***
Psychosocial health 67.68 (18.93) 75.86 (14.22)* 88.07 (11.28)***
Physical functioning 69.36 (23.05) 86.14 (13.69)*** 92.52 (10.47)***
Emotional functioning 70.00 (21.36) 70.28 (15.63) 85.00 (13.46)***
Social functioning 67.79 (27.07) 82.81 (15.54)** 93.16 (9.89)***
School functioning 62.90 (23.16) 74.44 (19.88)* 86.05 (14.57)***
SDQ child self-report n=26 n=39 n=41
Total difficulties 11.58 (5.69) 7.44 (4.79)** 5.71 (4.28)***
No.(%) caseness, 19–40 2 (8) 1 (3) ** 0 (0)**
No.(%) borderline, 16–18 6 (23) 0 (0) 1 (2)
Emotional problems 3.62 (2.10) 2.49 (2.11)* 1.80 (2.16)***
Conduct problems 1.85 (1.64) 2.10 (1.52) 1.80 (1.36)
Hyperactivity problems 3.58 (2.18) 3.05 (1.86) 3.27 (2.28)
Peer problems 2.54 (2.16) 2.33 (1.91) 1.56 (1.66)*
Prosocial behavior 7.89 (2.05) 7.64 (1.84) 7.85 (1.75)
Impact score 0.77 (1.42) 0.24 (0.68)* 0.24 (1.09)
No.(%) caseness, 2–10 6 (23) 3 (8) 2 (5)*
No.(%) borderline, 1 1 (4) 2 (5) 0 (0)
SDQ mother proxy-report n=31 n=36 n=38
Total difficulties 10.74 (6.30) 7.61 (5.15)* 4.18 (3.57)***
No.(%) caseness, 19-40 4 (13) 2 (6) 0 (0)**
No.(%) borderline, 16-18 3 (10) 3 (8) 0 (0)
Emotional problems 2.68 (1.97) 1.64 (1.81)* 0.76 (0.94)***
Conduct problems 1.81 (1.54) 1.50 (1.34) 0.95 (1.16)**
Hyperactivity problems 3.68 (2.50) 2.83 (2.66) 1.71 (1.98)**
Peer problems 2.58 (2.49) 1.64 (1.85) 0.76 (0.97)***
Prosocial behavior 7.81 (2.15) 7.97 (1.86) 8.87 (1.39)*
Impact score 1.19 (2.01) 1.59 (2.39) 0.03 (0.16)***
No.(%) caseness, 2–10 9 (29) 7 (19) 0 (0)***
No.(%) borderline, 1 0 (0) 0 (0) 1 (3)
Table 2 Health-related quality
of life and Strength and Diffi-
culties Questionnaire of 38 chil-
dren with kidney transplantation
(TX) compared to children with
ALL and healthy controls
*Significant at the 0.05 level
(two-tailed), **significant at
the 0.001 level (two-tailed),
***significant at the .001 level
(two-tailed) with respect to
difference between TX and
ALL/healthy patients/subjects
PedsQL, Pediatric Quality of
Life Inventory; SDQ, Strength
and Difficulties Questionnaire;
HRQOL, health-related quality
of life
Values are reported as the mean,
with the SD in parenthesis
unless stated otherwise
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reference values from the general Norwegian population
(mean 85.0, SD 12.3) [45]. When the patients were
classified according to parental donorship (n=27) or not,
the mothers in the parental donor group reported signifi-
cantly more mental health problems (GHQ) (t =2.15, p=
0.043) and a tendency towards significant lower QOL (t=
−2.01, p=0.056) than the mothers in the non-parental donor
group. All six GHQ cases were found in the parental donor
group.
Associations between physical variables, maternal variables
and children’s mental, psychosocial and QOL outcome
There were significant correlations between the measures of
physical status (height, BMI, CR Fitness), maternal
variables (GHQ, QOLS) and the children’s mental health/
psychosocial functioning (SDQ) and QOL (PedsQL) out-
comes (Table 3). Renal function (GFR) did not correlate
with any of these outcome variables. Strong associations
(r > 0.60, p < 0.001) were found between the PedsQL child
self-report and PedsQL mother proxy-report in all PedsQL
items, and between all SDQ child self-report and SDQ
mother proxy-report.
Increased mental health problems (SDQ) were for some
items significantly associated with physical outcomes—in
most areas with increased BMI, but in some areas also with
reduced CR Fitness and short stature—and with the
mothers psychological distress (GHQ) and poorer QOL
(QOLS).
Reduced PedsQL were for some items correlated with
physical outcomes—in most areas with short stature and
reduced CR Fitness, but in some areas also with increased
BMI—and with the mothers psychological distress (GHQ)
and poorer QOL (QOLS); see Table 3.
To investigate further the contribution of the independent
physical and maternal variables in predicting mental (SDQ
total score) and QOL (PedsQL total score) outcome, we
used a multiple linear regression analysis. With SDQ total
Variables/outcomes Height Body mass index CR Fitness Mothers GHQ Mothers QOL
Body mass index -
CR fitness 0.67*** −0.48*
Mothers GHQ - 0.37* -
Mothers QOLS - - - -0.57**
PedsQL child
Total 0.52** - 0.66*** - -
Psychosocial 0.56*** - 0.67*** - -
Physical - - 0.51* - -
Emotional 0.44* - 0.55* - -
Social 0.49** −0.56*** 0.50* - -
School - - 0.70*** - -
PedsQL mother
Total 0.45** −0.44* 0.59** - 0.52**
Psychosocial 0.45** −0.50** 0.59** - 0.52**
Physical 0.42* - 0.51* - 0.44*
Emotional - - - 0.43*
Social - −0.56*** 0.63** - -
School 0.38* - 0.49* −0.44* 0.59***
SDQ child
Total - 0.48* - - −0.46*
Emotional –0.42* - −0.53* - −0.49**
Peer - 0.57** - - -
Prosocial - −0.41* - - -
Impact - 0.46* - - −0.44*
SDQ mother
Total −0.36* 0.39* - - −0.48*
Emotional - - - −0.43*
Peer - 0.35* - 0.43* −0.59***
Prosocial - −0.46** 0.47* - -
Impact - - - - −0.47**
Table 3 Significant associations
between physical variables,
parental variables and children’s
mental, psychosocial and quality
of life outcomes
*Significant at the 0.05 level
(two-tailed), **significant at
the 0.001 level (two-tailed),
***significant at the .001 level
(two-tailed)
CR Fitness, Cardiorespiratory
fitness, was defined as maximal
oxygen uptake (V02peak)
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score as the dependent variable, we entered age, gender, the
physical correlates (height z score, BMI z score, VO2peak)
and maternal correlates (GHQ, QOLS) as explanatory vari-
ables (Table 4). The only significant predictor of mental
health outcome was the BMI z score, explaining 32% of the
variance (p=0.018).
Using the PedsQL total score as the dependent variable,
we entered age, gender, the physical correlates (height,
BMI, VO2peak) and the maternal correlates (GHQ, QOLS)
as explanatory variables. VO2peak was the only significant
predictor of QOL outcome (n=22), explaining 42% of the
variance (p=0.005).
Discussion
The results of our study show that mental health,
psychosocial adjustment and QOL of TX children are
significantly impaired on both self-reports and proxy-
reports compared with those of healthy controls and in
several areas, they are lower compared than those of the
ALL group. The children’s own perceived mental health
and HRQOL was related to physical functioning and
body composition, i.e. V02peak and BMI, respectively. The
mothers’ own mental health was significantly reduced
compared to that of the controls, but comparable to that
of ALL mothers. Our results demonstrate that both children
and their parents carry a significant burden that lasts up to
several years after kidney TX and therefore reflect the
documented psychological and social at-risk status for
children with chronic health conditions reported in the
literature [47, 48].
Our findings are consistent with those of studies using
PedsQL [8, 9, 21, 22] in which HRQOL was found to be
impaired in kidney TX children and adolescents in
comparison to healthy controls. The currently improving
medical strategies in renal TX have entailed an increased
awareness that the optimal care of children and adolescents
with ESRD requires attention not only to medical manage-
ment but also to the mental and psychosocial factors;
understanding this may provide insights into non-adherence
and non-compliance. Relatively few studies to date describe
these important aspects in pediatric kidney transplant
recipients and their parents, and those that do differ in their
methodology and generally present conflicting results.
Additionally, parents of children with serious or chronic
diseases may themselves be at risk for psychological
problems to the extent that they can no longer be an
effective source of protection and support for the child [49].
Thus, QOL should also include the long-term effects for the
whole family as well.
A lack of concordance between children and caregivers
has been reported in healthy [50] and chronically ill [51]
children, suggesting information provided by proxy
respondents is not equivalent to that reported by the patient.
The child perspective often diverges from parental percep-
tions, particularly in the emotional and social domains.
Previous research in CKD children and their parents has
emphasized that the caregivers’ perceptions of their child
may underestimate the patient’s own perception [8, 13]. On
the other hand, mothers with more psychological problems
often rate their children as having more behavioral prob-
lems [7].
In opposite to others [8, 13, 22], it is noteworthy that
our TX children and their mothers rate the child’s mental
health and quality of life in accordance to each other;
also in emotional and social domains. Our findings may
suggest that parental donors identify more with the child
due to organ share, in particular expressed by the
mothers since they were the ones that accompanied their
child to the investigations and thus were the responders
of the questionnaires.
Both TX children and their mothers reported signifi-
cantly lower HRQOL scores than children with ALL in
all areas except emotional functioning and higher SDQ
total difficulties, emotional problems and impact scores.
The two patient groups are equivalent in gender, age and
socio-economic background, such as family composition,
parental age and educational level, community, home and
economy, thus eliminating these factors as possible
confounders. Although ALL and renal TX are completely
different disease entities, our findings demonstrate a
greater total burden on the family and child after renal
TX. Our study further highlights the impact CKD may
have on HRQOL when compared to another severe
pediatric chronic disease [9].
The study on survivors of childhood ALL [27, 28] was
conducted at a mean of 7 years after treatment—which is a
time when the fear of relapse is less pronounced. Moreover,
ALL in children starts abruptly, the treatment period for
Table 4 Forward multiple regression analyses predicting mental health outcome (SDQ) and quality of life outcome (PedsQL) in children and
adolescents after transplantation
Model Independent variable B 95% Confidence interval Beta p value R2
1. SDQ Body mass index 1.79 (0.36, 3.23) 0.57 0.018 0.32
2. PedsQL VO2peak 0.22 (0.08, 0.36) 0.65 0.005 0.42
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most ALL children lasts 2–2.5 years and the follow-up at
the hospital ends 5–10 years after onset of disease. Renal
TX is for the majority preceded with years with CKD,
which affects both the child and its family. The frequent
hospital visits and daily medications continue after TX
and is a constant reminder of an everlasting chronic
disease [7, 52].
At the same time, renal TX is a milestone for many
families, even though the transition to normal life is
difficult for both the parents and the child. The relief
following regain of energy and appetite is hampered by
strict surveillance of medication and blood samples several
times a week in the early phase post TX. Parents may find it
difficult to wean off habits of overprotection established
before transplantation, reinforced by the wish to protect
both their child and their own donated organ. In addition,
the fear of rejection, non-compliance, risk of infections and
poor graft function is a persistent threat. Moreover,
approximately 50% of those transplanted in childhood will
need a second kidney transplant before the age of 25 years
[53].
Family functioning is one of the strongest contributors to
psychosocial adjustment both in children with chronic
health conditions and in healthy children [54]. It has been
suggested that kidney donation and Tx have far-reaching
implications for the whole family; each member will
experience different changes that affect the family environ-
ment as a whole and the QOL of each person uniquely [55].
While some studies have evaluated the psychosocial
functioning and QOL of CKD children and adolescents,
there has been a lack of studies on parents’ psychosocial
functioning and HRQOL. In our study, mothers of TX
children reported significantly more mental health problems
than mothers of healthy controls, but their scores were
comparable with those of the ALL mother comparison
group. This is in accordance with one of few studies
reporting that renal TX in children had a high impact on the
parents, such as social isolation, emotional dysfunctioning,
depression and posttraumatic stress symptoms [52]. Fur-
thermore, in our study, the mothers of children with a
parental donor had significantly more mental health prob-
lems than mothers of children receiving a kidney from non-
parental donors; this is worrying, even though the numbers
are low. This result is in contrast to previous research
finding that the great majority of kidney donors and their
partners experience no change or an improvement in their
psychosocial health after donation [56, 57]. In a country
like Norway, where LD in children has been a tradition
since the start of the program, it is especially important to
recognize the psychological trauma among the parental
donors. Parents are subjected to a process of conflicting
emotions. The donation of an organ is a life-saving
procedure. At the same time, the parental donors must
cope with the unspoken concern of own health after
donating a kidney. However, a more comprehensive
understanding of the psychological consequences of the
donation process on the parents requires further study in
which the fathers are also involved.
Most HRQOL studies on CKD children and adolescents
have highlighted the psychosocial effects with less attention
paid to its relation to physical effects [58]. In our study we
revealed that the health status variables BMI, height and
CR Fitness correlated and even predicted mental health
problems, psychosocial dysfunction and poor QOL. It is
now well established that short stature [59] is associated
with a negative impact on overall QOL.
Several studies have reported on the low exercise
capacity in CKD and ESRD children [19, 58, 60], but no
studies have as yet explored the relation between an
objective measure on CR Fitness (V02peak) and HRQOL
in renal TX children. Regular physical activity has been
shown to have significant physical and mental health
benefits [21, 61], including reduced anxiety, improved
body image, self-esteem, mood and quality of life. CR
Fitness (V02peak) is considered to be the best measure of
aerobic fitness and improves with exercise [62]. In a
previous study, we showed that renal TX children and
adolescents achieved only 66% of the expected CR Fitness
compared to healthy children and that the majority reported
being physical inactive [26]. Physical activity is a necessary
and natural constituent of a child’s life. However, the
fatigue of ESRD and the overprotection from parents and
the health system after TX may deprive these children from
participating in sports and activities. Physical inactivity is
in itself a risk factor for reduced self-esteem and obesity
and, perhaps most importantly, may impair social interac-
tion with peers and increase the risk for psychosocial
dysfunction.
Both short stature and physical inactivity may fore-
shadow poor long-term psychosocial outcomes that have
previously been observed and highlight the importance of
early interventions to improve both linear growth and
normalize height and to increase physical fitness in CKD
children.
Strength and limitations
The strength of our study is that the TX children were
followed-up at the same hospital and compared to a
relevant control group and comparison group. However, a
number of limitations should be noted. This study has a
cross-sectional design, and we were therefore unable to
control for premorbid functioning and for the small size of
our group of children and their mothers. Cross-sectional
designs cannot determine causal relations, implying that the
results should be treated with some caution.
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As for most studies on children and adolescents with
chronic diseases, including CKD, our study was based on self-
reports and/or parental questionnaires. These general non-
specific questionnaires underestimate the overall prevalence
of psychosocial dysfunctioning and psychopathology. More
specific psychosocial problems and mild psychopathology
appear to be difficult to elicit by questionnaires, indicating the
need for including semistructured psychiatric or qualitative
interviews within disease-specific areas. For future studies in
this field, one has to encourage both longitudinal and
qualitative studies to further explore QOL issues in renal TX
children, including patients with other types of solid organ TX
and utilizing transplant-specific HRQOL instruments in
addition to generic HRQOL measures [40].
Conclusion
Mental health problems and psychosocial dysfunction can
persist several years after diagnosis and treatment with
renal TX, affecting the TX child’s QOL and parental
functioning. Optimal treatment and follow-up of TX
children require close collaboration between pediatricians
and psychosocial experts from birth to adulthood. Profes-
sional mental health guidance which includes developmen-
tal and family perspectives should be offered routinely to
the TX patient and their parents.
With respect to the health status variables’ (height, BMI, CR
Fitness) impact onmental health andQOL, our study highlights
the importance of early interventions to improve linear growth,
reduce weight gain after TX and increase physical fitness. Our
results suggest that emphasis during the follow-up period of
entire family has also to be placed on physical rehabilitation
programs and even measurements of exercise capacity, as
compulsory therapy hand in hand with medical and psychoso-
cial support. Health care providers should be the first to inform
parents and the child about the importance of participating with
peers in play and sport. A holistic, multifactorial approach
towards the TX child and family is undoubtedly the best
strategy to achieve both long-term graft survival and ensure a
good QOL for both the child and parents.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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